These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
ý
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
For the Fiscal Year Ended December 31, 2017
|
¨
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
For the Transition Period from to
|
|
|
Delaware
|
|
76-0346924
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification No.)
|
|
Title of each class
|
|
Name of each exchange on which registered
|
Common Stock, $0.01 par value
|
|
New York Stock Exchange, Inc.
|
|
Large accelerated filer
x
|
|
Accelerated filer
¨
|
|
Non-accelerated filer
¨
|
|
Smaller reporting company
¨
|
|
|
|
|
(Do not check if a smaller
reporting company)
|
|
|
•
|
future operating rates, margins, cash flows and demand for our products;
|
•
|
industry market outlook, including the price of crude oil;
|
•
|
production capacities;
|
•
|
currency devaluation;
|
•
|
our ability to borrow additional funds under the Credit Agreement;
|
•
|
our ability to meet our liquidity needs;
|
•
|
our ability to meet debt obligations under our debt instruments;
|
•
|
our intended quarterly dividends;
|
•
|
future capacity additions and expansions in the industry;
|
•
|
timing, funding and results of capital projects, such as the expansion program at our Calvert City facility and the construction of the LACC plant;
|
•
|
pension plan obligations, funding requirements and investment policies;
|
•
|
compliance with present and future environmental regulations and costs associated with environmentally related penalties, capital expenditures, remedial actions and proceedings, including any new laws, regulations or treaties that may come into force to limit or control carbon dioxide and other GHG emissions or to address other issues of climate change;
|
•
|
effects of pending legal proceedings; and
|
•
|
timing of and amount of capital expenditures.
|
•
|
general economic and business conditions;
|
•
|
the cyclical nature of the chemical industry;
|
•
|
the availability, cost and volatility of raw materials and energy;
|
•
|
uncertainties associated with the United States, European and worldwide economies, including those due to political tensions and unrest in the Middle East, the Commonwealth of Independent States (including Ukraine) and elsewhere;
|
•
|
current and potential governmental regulatory actions in the United States and other countries and political unrest in other areas;
|
•
|
industry production capacity and operating rates;
|
•
|
the supply/demand balance for our products;
|
•
|
competitive products and pricing pressures;
|
•
|
instability in the credit and financial markets;
|
•
|
access to capital markets;
|
•
|
terrorist acts;
|
•
|
operating interruptions (including leaks, explosions, fires, weather-related incidents, mechanical failure, unscheduled downtime, labor difficulties, transportation interruptions, spills and releases and other environmental risks);
|
•
|
changes in laws or regulations;
|
•
|
technological developments;
|
•
|
foreign currency exchange risks;
|
•
|
our ability to implement our business strategies; and
|
•
|
creditworthiness of our customers.
|
Product
|
|
Annual Capacity
|
|
End Uses
|
|
|
|
(Millions of pounds)
|
|
|
|
Ethylene
(1)
|
|
2,990
|
|
|
Polyethylene, ethylene dichloride ("EDC"), styrene,
ethylene oxide/ethylene glycol
|
Low-Density Polyethylene ("LDPE")
|
|
1,500
|
|
|
High clarity packaging, shrink films, laundry and dry
cleaning bags, ice bags, frozen foods packaging, bakery
bags, coated paper board, cup stock, paper folding
cartons, lids, closures and general purpose molding
|
Linear Low-Density Polyethylene
("LLDPE")
|
|
1,070
|
|
|
Heavy-duty films and bags, general purpose liners
|
Styrene
|
|
570
|
|
|
Consumer disposables, packaging material, appliances,
paints and coatings, resins and building materials
|
(1)
|
Production capacity owned by OpCo.
|
Product
(1)
|
|
Annual Capacity
(2)
|
|
End Uses
|
|
|
|
(Millions of pounds)
|
|
|
|
Specialty PVC
|
|
1,100
|
|
|
Automotive sealants, cable sheathing, medical
applications and other applications
|
Commodity PVC
|
|
6,030
|
|
|
Construction materials including pipe, siding, profiles for
windows and doors, film and sheet for packaging
and other applications
|
VCM
|
|
7,480
|
|
|
PVC
|
Chlorine
|
|
7,140
|
|
|
VCM, organic/inorganic chemicals, bleach
|
Caustic Soda
|
|
7,860
|
|
|
Pulp and paper, organic/inorganic chemicals,
neutralization, alumina
|
Chlorinated Derivative Products
|
|
2,290
|
|
|
Coatings, flavorants, films, refrigerants, water treatment applications, chemicals and pharmaceutical production
|
Ethylene
(3)
|
|
730
|
|
|
VCM
|
Building Products
|
|
1,950
|
|
|
Pipe: water and sewer, plumbing, irrigation, conduit;
fittings; profiles and foundation building products;
window and door components; fence and deck
components; siding, trim and mouldings; film and sheet
|
(1)
|
EDC, a VCM intermediate product, is not included in the table.
|
(2)
|
Includes capacity related to our
95%
and
60%
owned Asian joint ventures.
|
(3)
|
Production capacity owned by OpCo.
|
•
|
During September 2010, our vinyls facilities in north Lake Charles and Plaquemine each received a Consolidated Compliance Order and Notice of Potential Penalty, alleging violations of various requirements of those facilities' air permits, based largely on self-reported permit deviations related to record-keeping violations. We have been negotiating a possible global settlement of these and several other matters with Louisiana Department of Environmental Quality. We believe the resolution of these matters may require the payment of a monetary sanction in excess of
$100,000
.
|
•
|
For several years, the EPA has been conducting an enforcement initiative against petroleum refineries and petrochemical plants with respect to emissions from flares. On April 21, 2014, we received a Clean Air Act Section 114 Information Request from the EPA which sought information regarding flares at the Calvert City, Kentucky facility and certain Lake Charles facilities. The EPA has informed us that the information provided leads the EPA to believe that some of the flares are out of compliance with applicable standards. The EPA has indicated that it is seeking a consent decree that would obligate us to take corrective actions relating to the alleged noncompliance. We believe the resolution of these matters may require the payment of a monetary sanction in excess of
$100,000
.
|
•
|
Regional offices of the EPA have investigated, and in some cases inspected, our compliance with Risk Management Program requirements under the Clean Air Act at our Calvert City, Kentucky; Natrium, West Virginia and Geismar, Louisiana facilities. We believe the resolution of these matters may require the payment of a monetary sanction in excess of $100,000.
|
•
|
In October 2017, the Enforcement Division of Kentucky Department of Environmental Protection ("KDEP") indicated that it intended to proceed with enforcement on two Notices of Violation ("NOVs") received by our Calvert City, Kentucky facility in December 2016 and May 2017. The NOVs allege violations of state and federal air requirements in connection with the operation of the olefins unit at the facility. We have engaged in negotiations with KDEP to resolve these alleged violations. We believe the resolution of these matters may require the payment of a monetary sanction in excess of $100,000.
|
Category
|
|
Number
|
|
Olefins segment
|
|
820
|
|
Vinyls segment
|
|
7,610
|
|
Corporate and other
|
|
370
|
|
•
|
general economic conditions, including in the United States, Europe and Asia;
|
•
|
new capacity additions in North America, Europe, Asia and the Middle East;
|
•
|
the level of business activity in the industries that use our products;
|
•
|
competitor action;
|
•
|
technological innovations;
|
•
|
currency fluctuations;
|
•
|
increases in interest rates;
|
•
|
international events and circumstances;
|
•
|
war, sabotage, terrorism and civil unrest;
|
•
|
governmental regulation, including in the United States, Europe and Asia;
|
•
|
severe weather and natural disasters; and
|
•
|
credit worthiness of customers and vendors.
|
•
|
product price;
|
•
|
balance of product supply/demand;
|
•
|
material, technology and process innovation;
|
•
|
technical support and customer service;
|
•
|
quality;
|
•
|
reliability of raw material and utility supply;
|
•
|
availability of potential substitute materials; and
|
•
|
product performance.
|
•
|
the emergence of new domestic and international competitors;
|
•
|
the rate of capacity additions by competitors;
|
•
|
changes in customer base due to mergers;
|
•
|
the intensification of price competition in our markets;
|
•
|
the introduction of new or substitute products by competitors; and
|
•
|
the technological innovations of competitors.
|
•
|
pipeline leaks and ruptures;
|
•
|
explosions;
|
•
|
fires;
|
•
|
severe weather and natural disasters;
|
•
|
mechanical failure;
|
•
|
unscheduled downtime;
|
•
|
labor difficulties;
|
•
|
transportation interruptions;
|
•
|
transportation accidents involving our chemical products;
|
•
|
remediation complications;
|
•
|
chemical spills;
|
•
|
discharges or releases of toxic or hazardous substances or gases;
|
•
|
storage tank leaks;
|
•
|
other environmental risks;
|
•
|
sabotage;
|
•
|
terrorist attacks; and
|
•
|
political unrest.
|
•
|
unexpectedly long delivery times for, or shortages of, key equipment, parts or materials;
|
•
|
shortages of skilled labor and other personnel necessary to perform the work;
|
•
|
delays and performance issues;
|
•
|
failures or delays of third-party equipment vendors or service providers;
|
•
|
unforeseen increases in the cost of equipment, labor and raw materials;
|
•
|
work stoppages and other labor disputes;
|
•
|
unanticipated actual or purported change orders;
|
•
|
disputes with contractors and suppliers;
|
•
|
design and engineering problems;
|
•
|
latent damages or deterioration to equipment and machinery in excess of engineering estimates and assumptions;
|
•
|
financial or other difficulties of our contractors and suppliers;
|
•
|
sabotage;
|
•
|
terrorist attacks;
|
•
|
interference from adverse weather conditions; and
|
•
|
difficulties in obtaining necessary permits or in meeting permit conditions.
|
•
|
a portion of our cash flows from operations will be dedicated to the payment of interest and principal on our debt and will not be available for other purposes;
|
•
|
we may not be able to obtain necessary financing in the future for working capital, capital expenditures, acquisitions, debt service requirements or other purposes;
|
•
|
our less leveraged competitors could have a competitive advantage because they have greater flexibility to utilize their cash flows to improve their operations;
|
•
|
we may be exposed to risks inherent in interest rate fluctuations because some of our borrowings are at variable rates of interest, which would result in higher interest expense in the event of increases in interest rates;
|
•
|
we could be vulnerable in the event of a downturn in our business that would leave us less able to take advantage of significant business opportunities and to react to changes in our business and in market or industry conditions; and
|
•
|
should we pursue additional expansions of existing assets or acquisition of third party assets, we may not be able to obtain additional liquidity at cost effective interest rates.
|
•
|
pay dividends on, redeem or repurchase our capital stock;
|
•
|
make investments and other restricted payments;
|
•
|
incur additional indebtedness or issue preferred stock;
|
•
|
create liens;
|
•
|
permit dividend or other payment restrictions on our restricted subsidiaries;
|
•
|
sell all or substantially all of our assets or consolidate or merge with or into other companies;
|
•
|
engage in transactions with affiliates; and
|
•
|
engage in sale-leaseback transactions.
|
•
|
shortages and inconsistent quality of equipment, materials, and labor;
|
•
|
labor costs and productivity;
|
•
|
work stoppages;
|
•
|
contractor or supplier delay or non-performance under construction or other agreements or non-performance by other major participants in construction projects;
|
•
|
delays in or failure to receive necessary permits, approvals, tax credits, and other regulatory authorizations;
|
•
|
delays associated with start-up activities, including major equipment failure, system integration, and operations, and/or unforeseen engineering problems;
|
•
|
changes in project design or scope;
|
•
|
impacts of new and existing laws and regulations, including environmental laws and regulations;
|
•
|
the outcome of legal challenges to projects, including legal challenges to regulatory approvals;
|
•
|
failure to construct in accordance with licensing requirements;
|
•
|
continued public and policymaker support for such projects;
|
•
|
adverse weather conditions or natural disasters;
|
•
|
sabotage;
|
•
|
terrorist attacks;
|
•
|
environmental and geological conditions;
|
•
|
delays or increased costs to interconnect facilities; and
|
•
|
other unanticipated cost increases.
|
•
|
we may fail to integrate the businesses we acquire into a cohesive, efficient enterprise;
|
•
|
our resources, including management resources, are limited and may be strained if we engage in a large acquisition or significant number of acquisitions, and acquisitions may divert our management's attention from initiating or carrying out programs to save costs or enhance revenues; and
|
•
|
our failure to retain key employees and contracts of the businesses we acquire.
|
•
|
diversion of management's attention away from normal daily business operations;
|
•
|
delays and cost overruns;
|
•
|
loss of or delays in accessing data;
|
•
|
increased demand on our operations support personnel;
|
•
|
initial dependence on unfamiliar systems while training personnel to use new systems; and
|
•
|
increased operating expenses resulting from training, conversion and transition support activities.
|
•
|
the composition of our Board of Directors and, through the Board, any determination with respect to our business direction and policies, including the appointment and removal of officers and the determination of compensation;
|
•
|
any determinations with respect to mergers or other business combinations or the acquisition or disposition of assets;
|
•
|
our financing decisions, capital raising activities and the payment of dividends; and
|
•
|
amendments to our amended and restated certificate of incorporation or amended and restated bylaws.
|
•
|
business opportunities that may be presented to the principal stockholder affiliates and to our officers and directors associated with the principal stockholder affiliates, and competition between the principal stockholder affiliates and us within the same lines of business;
|
•
|
the solicitation and hiring of employees from each other; and
|
•
|
agreements with the principal stockholder affiliates relating to corporate services that may be material to our business.
|
Location
|
|
Principal Products
|
Lake Charles, Louisiana
|
|
Ethylene, polyethylene, styrene, VCM, chlorine, caustic soda,
chlorinated derivative products, electricity
|
Longview, Texas
(1)
|
|
Polyethylene, polyethylene wax
|
Calvert City, Kentucky
(2)
|
|
PVC, VCM, chlorine, caustic soda, ethylene
|
Plaquemine, Louisiana
|
|
PVC, VCM, chlorine, caustic soda, electricity
|
Geismar, Louisiana
|
|
PVC, VCM, chlorine, caustic soda
|
Gendorf, Bavaria, Germany
(1)
|
|
PVC, VCM, chlorine, caustic soda
|
Burghausen, Bavaria, Germany
(1)
|
|
PVC
|
Knapsack, North Rhine-Westphalia, Germany
(1)
|
|
PVC, VCM, chlorine, caustic soda
|
Cologne, North Rhine-Westphalia, Germany
(1)
|
|
PVC
|
(1)
|
We lease the land on which our facilities are located.
|
(2)
|
We lease a portion of the land on which our Calvert City facility is located.
|
|
|
High
|
|
Low
|
|
Cash Dividends
Declared
|
||||||
Year Ended December 31, 2017
|
|
|
|
|
|
|
||||||
4th Quarter
|
|
$
|
106.53
|
|
|
$
|
83.10
|
|
|
$
|
0.2100
|
|
3rd Quarter
|
|
83.55
|
|
|
65.85
|
|
|
0.2100
|
|
|||
2nd Quarter
|
|
67.34
|
|
|
60.09
|
|
|
0.1906
|
|
|||
1st Quarter
|
|
67.21
|
|
|
57.29
|
|
|
0.1906
|
|
|||
Year Ended December 31, 2016
|
|
|
|
|
|
|
||||||
4th Quarter
|
|
$
|
59.17
|
|
|
$
|
49.84
|
|
|
$
|
0.1906
|
|
3rd Quarter
|
|
53.50
|
|
|
41.21
|
|
|
0.1906
|
|
|||
2nd Quarter
|
|
52.22
|
|
|
39.88
|
|
|
0.1815
|
|
|||
1st Quarter
|
|
53.60
|
|
|
41.01
|
|
|
0.1815
|
|
Period
|
|
Total Number
of Shares
Purchased
(1)
|
|
Average Price
Paid Per
Share
|
|
Total Number
of Shares
Purchased as Part
of Publicly
Announced Plans
or Programs
(2)
|
|
Maximum Number
(or Approximate
Dollar Value) of
Shares that
May Yet Be
Purchased Under the
Plans or Programs
(2)
|
||||||
October 2017
|
|
3,202
|
|
|
$
|
83.28
|
|
|
—
|
|
|
$
|
171,285,000
|
|
November 2017
|
|
—
|
|
|
$
|
—
|
|
|
—
|
|
|
$
|
171,285,000
|
|
December 2017
|
|
—
|
|
|
$
|
—
|
|
|
—
|
|
|
$
|
171,285,000
|
|
Total
|
|
3,202
|
|
|
$
|
83.28
|
|
|
—
|
|
|
|
(1)
|
Represents shares withheld in satisfaction of withholding taxes due upon the vesting of restricted stock units granted to our employees under the 2013 Plan.
|
(2)
|
In November 2014, our Board of Directors authorized a $250 million stock repurchase program (the "2014 Program"). In November 2015, our Board of Directors approved the expansion of the 2014 Program by an additional $150 million. As of
December 31, 2017
,
4,193,598
shares of our common stock had been acquired at an aggregate purchase price of approximately
$229 million
under the 2014 Program. Transaction fees and commissions are not reported in the average price paid per share in the table above. Decisions regarding the amount and the timing of purchases under the 2014 Program will be influenced by our cash on hand, our cash flows from operations, general market conditions and other factors. The 2014 Program may be discontinued by our Board of Directors at any time.
|
Plan Category
|
|
Number of securities
to be issued upon
exercise of outstanding options,
warrants and rights
(a)
|
|
Weighted-average
exercise price of
outstanding
options, warrants
and rights
(b)
|
|
Number of securities
remaining available
for future issuance under equity
compensation plans
(excluding securities
reflected in column
(a))
(c)
|
||||
Equity compensation plans approved by security holders
|
|
1,933,467
|
|
|
$
|
26.95
|
|
|
4,855,527
|
|
Equity compensation plans not approved by security holders
|
|
N/A
|
|
|
N/A
|
|
|
N/A
|
|
|
Total
|
|
1,933,467
|
|
|
$
|
26.95
|
|
|
4,855,527
|
|
|
|
Year Ended December 31,
|
||||||||||||||||||
|
|
2017
|
|
2016
|
|
2015
|
|
2014
|
|
2013
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
(dollars in millions, except share amounts, per share data and volume data)
|
||||||||||||||||||
Statement of Operations Data:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Net sales
|
|
$
|
8,041
|
|
|
$
|
5,076
|
|
|
$
|
4,463
|
|
|
$
|
4,415
|
|
|
$
|
3,759
|
|
Gross profit
|
|
1,769
|
|
|
981
|
|
|
1,185
|
|
|
1,317
|
|
|
1,101
|
|
|||||
Selling, general and administrative expenses
|
|
399
|
|
|
258
|
|
|
218
|
|
|
179
|
|
|
144
|
|
|||||
Amortization of intangibles
|
|
108
|
|
|
38
|
|
|
7
|
|
|
5
|
|
|
4
|
|
|||||
Transaction and integration-related costs
|
|
29
|
|
|
104
|
|
|
—
|
|
|
9
|
|
|
—
|
|
|||||
Income from operations
|
|
1,233
|
|
|
581
|
|
|
960
|
|
|
1,124
|
|
|
953
|
|
|||||
Interest expense
|
|
(159
|
)
|
|
(79
|
)
|
|
(35
|
)
|
|
(37
|
)
|
|
(18
|
)
|
|||||
Other income (expense), net
(2)
|
|
7
|
|
|
56
|
|
|
38
|
|
|
(3
|
)
|
|
7
|
|
|||||
Income before income taxes
|
|
1,081
|
|
|
558
|
|
|
963
|
|
|
1,084
|
|
|
942
|
|
|||||
Provision for (benefit from) income taxes
|
|
(258
|
)
|
|
138
|
|
|
298
|
|
|
399
|
|
|
332
|
|
|||||
Net income
|
|
1,339
|
|
|
420
|
|
|
665
|
|
|
685
|
|
|
610
|
|
|||||
Net income attributable to noncontrolling
interests
|
|
35
|
|
|
21
|
|
|
19
|
|
|
6
|
|
|
—
|
|
|||||
Net income attributable to
Westlake Chemical Corporation
|
|
$
|
1,304
|
|
|
$
|
399
|
|
|
$
|
646
|
|
|
$
|
679
|
|
|
$
|
610
|
|
Earnings Per Share Attributable to
Westlake Chemical Corporation:
(3)
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Basic
|
|
$
|
10.05
|
|
|
$
|
3.07
|
|
|
$
|
4.88
|
|
|
$
|
5.09
|
|
|
$
|
4.57
|
|
Diluted
|
|
$
|
10.00
|
|
|
$
|
3.06
|
|
|
$
|
4.86
|
|
|
$
|
5.07
|
|
|
$
|
4.55
|
|
Weighted average shares outstanding
(3)
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Basic
|
|
129,087,043
|
|
|
129,367,712
|
|
|
131,823,707
|
|
|
133,111,230
|
|
|
133,224,256
|
|
|||||
Diluted
|
|
129,540,013
|
|
|
129,974,822
|
|
|
132,301,812
|
|
|
133,643,414
|
|
|
133,779,250
|
|
|||||
Balance Sheet Data (end of period):
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Cash and cash equivalents
|
|
$
|
1,531
|
|
|
$
|
459
|
|
|
$
|
663
|
|
|
$
|
881
|
|
|
$
|
461
|
|
Marketable securities
|
|
—
|
|
|
—
|
|
|
520
|
|
|
—
|
|
|
239
|
|
|||||
Restricted cash
|
|
1
|
|
|
161
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Working capital
(4)
|
|
1,496
|
|
|
1,225
|
|
|
1,652
|
|
|
1,475
|
|
|
1,244
|
|
|||||
Total assets
|
|
12,076
|
|
|
10,890
|
|
|
5,569
|
|
|
5,208
|
|
|
4,054
|
|
|||||
Total long-term debt, net
|
|
3,127
|
|
|
3,679
|
|
|
758
|
|
|
758
|
|
|
757
|
|
|||||
Total Westlake Chemical Corporation
stockholders' equity
|
|
4,874
|
|
|
3,524
|
|
|
3,266
|
|
|
2,912
|
|
|
2,419
|
|
|||||
Cash dividends declared per share
(3)
|
|
$
|
0.8012
|
|
|
$
|
0.7442
|
|
|
$
|
0.6930
|
|
|
$
|
0.5820
|
|
|
$
|
0.4125
|
|
Other Operating Data:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Cash flows from:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Operating activities
|
|
$
|
1,538
|
|
|
$
|
834
|
|
|
$
|
1,079
|
|
|
$
|
1,032
|
|
|
$
|
753
|
|
Investing activities
|
|
(652
|
)
|
|
(2,563
|
)
|
|
(1,006
|
)
|
|
(773
|
)
|
|
(1,002
|
)
|
|||||
Financing activities
|
|
160
|
|
|
1,533
|
|
|
(287
|
)
|
|
165
|
|
|
(80
|
)
|
|||||
Depreciation and amortization
|
|
601
|
|
|
378
|
|
|
246
|
|
|
208
|
|
|
158
|
|
|||||
Capital expenditures
|
|
577
|
|
|
629
|
|
|
491
|
|
|
431
|
|
|
679
|
|
|||||
EBITDA
(5)
|
|
1,841
|
|
|
1,015
|
|
|
1,244
|
|
|
1,329
|
|
|
1,118
|
|
|
|
Year Ended December 31,
|
||||||||||||||||||
|
|
2017
|
|
2016
|
|
2015
|
|
2014
|
|
2013
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
(dollars in millions, except share amounts, per share data and volume data)
|
||||||||||||||||||
External Sales Volume
(millions of pounds):
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Olefins Segment
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Polyethylene
|
|
2,363
|
|
|
2,392
|
|
|
2,445
|
|
|
2,364
|
|
|
2,244
|
|
|||||
Styrene, feedstock and other
|
|
828
|
|
|
794
|
|
|
1,182
|
|
|
941
|
|
|
1,094
|
|
|||||
Vinyls Segment
|
|
|
|
|
|
|
|
|
|
|
||||||||||
PVC, caustic soda and other
|
|
15,997
|
|
|
8,118
|
|
|
5,026
|
|
|
3,174
|
|
|
1,995
|
|
|||||
Building products
|
|
1,193
|
|
|
770
|
|
|
629
|
|
|
572
|
|
|
487
|
|
(1)
|
The historical selected financial and operational data should be read together with Item 7, Management's Discussion and Analysis of Financial Condition and Results of Operations, and Item 8, Financial Statements and Supplementary Data included in this Form 10-K.
|
(2)
|
Other income (expense), net is composed of the realized gain from previously held outstanding shares of common stock of Axiall, financing costs incurred in connection with the Merger, interest income, income or loss from equity method investments, dividend income, gains or losses from sales of securities, foreign exchange currency gains or losses, gain on acquisition, impairment of equity method investments, management fee income and other gains and losses.
|
(3)
|
On February 14, 2014, our Board of Directors authorized a two-for-one split of our common stock. Stockholders of record as of February 28, 2014 were entitled to one additional share for every share outstanding, which was distributed on March 18, 2014. All share amounts and per share data for the year ended December 31, 2013 have been restated to reflect the effect of the two-for-one stock split.
|
(4)
|
Working capital equals current assets less current liabilities.
|
(5)
|
EBITDA (a non-GAAP financial measure) is calculated as net income before interest expense, income taxes, depreciation and amortization. The body of accounting principles generally accepted in the United States is commonly referred to as "GAAP." For this purpose a non-GAAP financial measure is generally defined by the Securities and Exchange Commission ("SEC") as one that purports to measure historical and future financial performance, financial position or cash flows, but excludes or includes amounts that would not be so adjusted in the most comparable GAAP measures. We have included EBITDA in this Form 10-K because our management considers it an important supplemental measure of our performance and believes that it is frequently used by securities analysts, investors and other interested parties in the evaluation of companies in our industry, some of which present EBITDA when reporting their results. We regularly evaluate our performance as compared to other companies in our industry that have different financing and capital structures and/or tax rates by using EBITDA. EBITDA allows for meaningful company-to-company performance comparisons by adjusting for factors such as interest expense, depreciation and amortization and taxes, which often vary from company to company. In addition, we utilize EBITDA in evaluating acquisition targets. Management also believes that EBITDA is a useful tool for measuring our ability to meet our future debt service, capital expenditures and working capital requirements, and EBITDA is commonly used by us and our investors to measure our ability to service indebtedness. EBITDA is not a substitute for the GAAP measures of earnings or of cash flows and is not necessarily a measure of our ability to fund our cash needs. In addition, it should be noted that companies calculate EBITDA differently and, therefore, EBITDA as presented in this Form 10-K may not be comparable to EBITDA reported by other companies. EBITDA has material limitations as a performance measure because it excludes (1) interest expense, which is a necessary element of our costs and ability to generate revenues because we have borrowed money to finance our operations, (2) depreciation, which is a necessary element of our costs and ability to generate revenues because we use capital assets and (3) income taxes, which is a necessary element of our operations. We compensate for these limitations by relying primarily on our GAAP results and using EBITDA only supplementally. The following table reconciles EBITDA to net income and to net cash provided by operating activities.
|
|
|
Year Ended December 31,
|
||||||||||||||||||
|
|
2017
|
|
2016
|
|
2015
|
|
2014
|
|
2013
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
(dollars in millions)
|
||||||||||||||||||
Net cash provided by operating activities
|
|
$
|
1,538
|
|
|
$
|
834
|
|
|
$
|
1,079
|
|
|
$
|
1,032
|
|
|
$
|
753
|
|
Changes in operating assets and liabilities
and other |
|
(733
|
)
|
|
(313
|
)
|
|
(374
|
)
|
|
(288
|
)
|
|
(49
|
)
|
|||||
Deferred income taxes
|
|
534
|
|
|
(101
|
)
|
|
(40
|
)
|
|
(59
|
)
|
|
(94
|
)
|
|||||
Net income
|
|
1,339
|
|
|
420
|
|
|
665
|
|
|
685
|
|
|
610
|
|
|||||
Add:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Depreciation and amortization
|
|
601
|
|
|
378
|
|
|
246
|
|
|
208
|
|
|
158
|
|
|||||
Interest expense
|
|
159
|
|
|
79
|
|
|
35
|
|
|
37
|
|
|
18
|
|
|||||
Provision for (benefit from) income taxes
|
|
(258
|
)
|
|
138
|
|
|
298
|
|
|
399
|
|
|
332
|
|
|||||
EBITDA
|
|
$
|
1,841
|
|
|
$
|
1,015
|
|
|
$
|
1,244
|
|
|
$
|
1,329
|
|
|
$
|
1,118
|
|
•
|
the availability of feedstock from shale gas and oil drilling;
|
•
|
supply and demand for crude oil;
|
•
|
shortages of raw materials due to increasing demand;
|
•
|
ethane and liquefied natural gas exports;
|
•
|
capacity constraints due to higher construction costs for investments, construction delays, strike action or involuntary shutdowns;
|
•
|
the general level of business and economic activity; and
|
•
|
the direct or indirect effect of governmental regulation.
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2017
|
|
2016
|
|
2015
|
||||||
|
|
|
|
|
|
|
||||||
|
|
(dollars in millions, except per share data)
|
||||||||||
Net external sales
|
|
|
|
|
|
|
||||||
Olefins
|
|
|
|
|
|
|
||||||
Polyethylene
|
|
$
|
1,518
|
|
|
$
|
1,463
|
|
|
$
|
1,651
|
|
Styrene, feedstock and other
|
|
533
|
|
|
431
|
|
|
609
|
|
|||
Total Olefins
|
|
2,051
|
|
|
1,894
|
|
|
2,260
|
|
|||
Vinyls
|
|
|
|
|
|
|
||||||
PVC, caustic soda and other
|
|
4,769
|
|
|
2,493
|
|
|
1,718
|
|
|||
Building products
|
|
1,221
|
|
|
689
|
|
|
485
|
|
|||
Total Vinyls
|
|
5,990
|
|
|
3,182
|
|
|
2,203
|
|
|||
Total
|
|
$
|
8,041
|
|
|
$
|
5,076
|
|
|
$
|
4,463
|
|
|
|
|
|
|
|
|
||||||
Income (loss) from operations
|
|
|
|
|
|
|
||||||
Olefins
|
|
$
|
655
|
|
|
$
|
558
|
|
|
$
|
747
|
|
Vinyls
|
|
647
|
|
|
174
|
|
|
255
|
|
|||
Corporate and other
|
|
(69
|
)
|
|
(151
|
)
|
|
(42
|
)
|
|||
Total income from operations
|
|
1,233
|
|
|
581
|
|
|
960
|
|
|||
Interest expense
|
|
(159
|
)
|
|
(79
|
)
|
|
(35
|
)
|
|||
Other income (expense), net
|
|
7
|
|
|
56
|
|
|
38
|
|
|||
Provision for (benefit from) income taxes
|
|
(258
|
)
|
|
138
|
|
|
298
|
|
|||
Net income
|
|
1,339
|
|
|
420
|
|
|
665
|
|
|||
Net income attributable to noncontrolling interests
|
|
35
|
|
|
21
|
|
|
19
|
|
|||
Net income attributable to Westlake Chemical Corporation
|
|
$
|
1,304
|
|
|
$
|
399
|
|
|
$
|
646
|
|
Diluted earnings per share
|
|
$
|
10.00
|
|
|
$
|
3.06
|
|
|
$
|
4.86
|
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2017
|
|
2016
|
||||||||
|
|
Average Sales
Price
|
|
Volume
|
|
Average Sales
Price
|
|
Volume
|
||||
Product sales price and volume percentage change
from prior year
|
|
|
|
|
|
|
|
|
||||
Olefins
|
|
+9
|
%
|
|
-1
|
%
|
|
-9
|
%
|
|
-7
|
%
|
Vinyls
|
|
+14
|
%
|
|
+74
|
%
|
|
-4
|
%
|
|
+48
|
%
|
Company average
|
|
+12
|
%
|
|
+46
|
%
|
|
-6
|
%
|
|
+20
|
%
|
|
|
Year Ended December 31,
|
|||||||
|
|
2017
|
|
2016
|
|
2015
|
|||
Average industry prices
(1)
|
|
|
|
|
|
|
|||
Ethane (cents/lb)
|
|
8.3
|
|
|
6.6
|
|
|
6.2
|
|
Propane (cents/lb)
|
|
18.1
|
|
|
11.4
|
|
|
10.7
|
|
Ethylene (cents/lb)
(2)
|
|
28.0
|
|
|
26.9
|
|
|
30.6
|
|
Polyethylene (cents/lb)
(3)
|
|
71.1
|
|
|
65.3
|
|
|
71.6
|
|
Styrene (cents/lb)
(4)
|
|
86.5
|
|
|
64.8
|
|
|
60.7
|
|
Caustic ($/short ton)
(5)
|
|
800.4
|
|
|
645.0
|
|
|
581.0
|
|
Chlorine ($/short ton)
(6)
|
|
323.8
|
|
|
297.7
|
|
|
266.9
|
|
PVC (cents/lb)
(7)
|
|
62.6
|
|
|
54.7
|
|
|
51.0
|
|
(1)
|
Industry pricing data was obtained through IHS. We have not independently verified the data.
|
(2)
|
Represents average North American spot prices of ethylene over the period as reported by IHS.
|
(3)
|
Represents average North American net transaction prices of polyethylene low density GP-Film grade over the period as reported by IHS.
|
(4)
|
Represents average North American contract prices of styrene over the period as reported by IHS.
|
(5)
|
Represents average North American undiscounted contract prices of caustic soda over the period as reported by IHS.
|
(6)
|
Represents average North American contract prices of chlorine (into chemicals) over the period as reported by IHS.
|
(7)
|
Represents average North American contract prices of PVC over the period as reported by IHS. Effective January 1, 2017, IHS made a non-market downward adjustment of 15 cents per pound to PVC prices. For comparability, we adjusted each prior-year period's PVC price downward by 15 cents per pound consistent with the IHS non-market adjustment.
|
|
|
Payment Due by Period
|
||||||||||||||||||
|
|
Total
|
|
2018
|
|
2019-2020
|
|
2021-2022
|
|
Thereafter
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
(dollars in millions)
|
||||||||||||||||||
Contractual Obligations
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Long-term debt
|
|
$
|
3,853
|
|
|
$
|
688
|
|
|
$
|
—
|
|
|
$
|
250
|
|
|
$
|
2,915
|
|
Operating leases
|
|
1,029
|
|
|
108
|
|
|
170
|
|
|
100
|
|
|
651
|
|
|||||
Capital leases
|
|
22
|
|
|
3
|
|
|
6
|
|
|
4
|
|
|
9
|
|
|||||
Pension benefits funding
|
|
143
|
|
|
6
|
|
|
11
|
|
|
15
|
|
|
111
|
|
|||||
Post-retirement healthcare benefits
|
|
110
|
|
|
8
|
|
|
16
|
|
|
16
|
|
|
70
|
|
|||||
Purchase obligations
|
|
5,264
|
|
|
1,522
|
|
|
1,777
|
|
|
1,080
|
|
|
885
|
|
|||||
Interest payments
|
|
2,438
|
|
|
144
|
|
|
280
|
|
|
276
|
|
|
1,738
|
|
|||||
Asset retirement obligations
|
|
38
|
|
|
4
|
|
|
2
|
|
|
1
|
|
|
31
|
|
|||||
Investment in LACC
|
|
100
|
|
|
54
|
|
|
46
|
|
|
—
|
|
|
—
|
|
|||||
Total
|
|
$
|
12,997
|
|
|
$
|
2,537
|
|
|
$
|
2,308
|
|
|
$
|
1,742
|
|
|
$
|
6,410
|
|
Other Commercial Commitments
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Standby letters of credit
|
|
$
|
47
|
|
|
$
|
41
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
6
|
|
|
|
2017
|
||||||
|
|
U.S. Plans
|
|
Non-U.S. Plans
|
||||
|
|
|
|
|
||||
|
|
(dollars in millions)
|
||||||
Projected benefit obligation, end of year
|
|
$
|
807
|
|
|
$
|
128
|
|
Discount rate increases by 100 basis points
|
|
(88
|
)
|
|
(20
|
)
|
||
Discount rate decreases by 100 basis points
|
|
107
|
|
|
26
|
|
Item 8.
|
Financial Statements and Supplementary Data
|
|
Page
|
|
|
Management's Report on Internal Control over Financial Reporting
|
|
Report of Independent Registered Public Accounting Firm
|
|
Consolidated Financial Statements:
|
|
Consolidated Balance Sheets as of December 31, 2017 and 2016
|
|
Consolidated Statements of Operations for the Years Ended December 31, 2017, 2016 and 2015
|
|
Consolidated Statements of Comprehensive Income for the Years Ended
December 31, 2017, 2016 and 2015
|
|
Consolidated Statements of Changes in Stockholders' Equity for the Years Ended
December 31, 2017, 2016 and 2015
|
|
Consolidated Statements of Cash Flows for the Years Ended December 31, 2017, 2016 and 2015
|
|
Notes to Consolidated Financial Statements
|
|
|
December 31,
|
||||||
|
|
2017
|
|
2016
|
||||
|
|
|
|
|
||||
|
|
(in millions of dollars, except
par values and share amounts)
|
||||||
ASSETS
|
|
|
|
|
||||
Current assets
|
|
|
|
|
||||
Cash and cash equivalents
|
|
$
|
1,531
|
|
|
$
|
459
|
|
Accounts receivable, net
|
|
1,001
|
|
|
939
|
|
||
Inventories
|
|
900
|
|
|
801
|
|
||
Prepaid expenses and other current assets
|
|
30
|
|
|
48
|
|
||
Restricted cash
|
|
1
|
|
|
161
|
|
||
Total current assets
|
|
3,463
|
|
|
2,408
|
|
||
Property, plant and equipment, net
|
|
6,412
|
|
|
6,420
|
|
||
Goodwill
|
|
1,012
|
|
|
947
|
|
||
Customer relationships, net
|
|
616
|
|
|
611
|
|
||
Other intangible assets, net
|
|
161
|
|
|
176
|
|
||
Other assets, net
|
|
412
|
|
|
328
|
|
||
Total assets
|
|
$
|
12,076
|
|
|
$
|
10,890
|
|
LIABILITIES AND EQUITY
|
|
|
|
|
||||
Current liabilities
|
|
|
|
|
||||
Accounts payable
|
|
$
|
600
|
|
|
$
|
496
|
|
Accrued liabilities
|
|
657
|
|
|
538
|
|
||
Current portion of long-term debt, net
|
|
710
|
|
|
—
|
|
||
Term loan
|
|
—
|
|
|
149
|
|
||
Total current liabilities
|
|
1,967
|
|
|
1,183
|
|
||
Long-term debt, net
|
|
3,127
|
|
|
3,679
|
|
||
Deferred income taxes
|
|
1,111
|
|
|
1,650
|
|
||
Pension and other post-retirement benefits
|
|
344
|
|
|
365
|
|
||
Other liabilities
|
|
158
|
|
|
121
|
|
||
Total liabilities
|
|
6,707
|
|
|
6,998
|
|
||
Commitments and contingencies (Note 20)
|
|
|
|
|
|
|
||
Stockholders' equity
|
|
|
|
|
||||
Preferred stock, $0.01 par value, 50,000,000 shares authorized; no shares
issued and outstanding
|
|
—
|
|
|
—
|
|
||
Common stock, $0.01 par value, 300,000,000 shares authorized; 134,651,380 and
134,651,380 shares issued at December 31, 2017 and 2016, respectively
|
|
1
|
|
|
1
|
|
||
Common stock, held in treasury, at cost; 5,232,875 and 5,726,377 shares
at December 31, 2017 and 2016, respectively
|
|
(302
|
)
|
|
(319
|
)
|
||
Additional paid-in capital
|
|
555
|
|
|
551
|
|
||
Retained earnings
|
|
4,613
|
|
|
3,412
|
|
||
Accumulated other comprehensive income (loss)
|
|
7
|
|
|
(121
|
)
|
||
Total Westlake Chemical Corporation stockholders' equity
|
|
4,874
|
|
|
3,524
|
|
||
Noncontrolling interests
|
|
495
|
|
|
368
|
|
||
Total equity
|
|
5,369
|
|
|
3,892
|
|
||
Total liabilities and equity
|
|
$
|
12,076
|
|
|
$
|
10,890
|
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2017
|
|
2016
|
|
2015
|
||||||
|
|
|
|
|
|
|
||||||
|
|
(in millions of dollars,
except share amounts and per share data)
|
||||||||||
Net sales
|
|
$
|
8,041
|
|
|
$
|
5,076
|
|
|
$
|
4,463
|
|
Cost of sales
|
|
6,272
|
|
|
4,095
|
|
|
3,278
|
|
|||
Gross profit
|
|
1,769
|
|
|
981
|
|
|
1,185
|
|
|||
Selling, general and administrative expenses
|
|
399
|
|
|
258
|
|
|
218
|
|
|||
Amortization of intangibles
|
|
108
|
|
|
38
|
|
|
7
|
|
|||
Transaction and integration-related costs
|
|
29
|
|
|
104
|
|
|
—
|
|
|||
Income from operations
|
|
1,233
|
|
|
581
|
|
|
960
|
|
|||
Other income (expense)
|
|
|
|
|
|
|
||||||
Interest expense
|
|
(159
|
)
|
|
(79
|
)
|
|
(35
|
)
|
|||
Other income, net
|
|
7
|
|
|
56
|
|
|
38
|
|
|||
Income before income taxes
|
|
1,081
|
|
|
558
|
|
|
963
|
|
|||
Provision for (benefit from) income taxes
|
|
(258
|
)
|
|
138
|
|
|
298
|
|
|||
Net income
|
|
1,339
|
|
|
420
|
|
|
665
|
|
|||
Net income attributable to noncontrolling interests
|
|
35
|
|
|
21
|
|
|
19
|
|
|||
Net income attributable to Westlake Chemical Corporation
|
|
$
|
1,304
|
|
|
$
|
399
|
|
|
$
|
646
|
|
Earnings per common share attributable to
Westlake Chemical Corporation:
|
|
|
|
|
|
|
||||||
Basic
|
|
$
|
10.05
|
|
|
$
|
3.07
|
|
|
$
|
4.88
|
|
Diluted
|
|
$
|
10.00
|
|
|
$
|
3.06
|
|
|
$
|
4.86
|
|
Weighted average shares outstanding
|
|
|
|
|
|
|
||||||
Basic
|
|
129,087,043
|
|
|
129,367,712
|
|
|
131,823,707
|
|
|||
Diluted
|
|
129,540,013
|
|
|
129,974,822
|
|
|
132,301,812
|
|
|||
Dividends per common share
|
|
$
|
0.8012
|
|
|
$
|
0.7442
|
|
|
$
|
0.6930
|
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2017
|
|
2016
|
|
2015
|
||||||
|
|
|
|
|
|
|
||||||
|
|
(in millions of dollars)
|
||||||||||
Net income
|
|
$
|
1,339
|
|
|
$
|
420
|
|
|
$
|
665
|
|
Other comprehensive income (loss), net of income taxes
|
|
|
|
|
|
|
||||||
Pension and other post-retirement benefits liability
|
|
|
|
|
|
|
||||||
Pension and other post-retirement reserves adjustment
(excluding amortization)
|
|
19
|
|
|
60
|
|
|
18
|
|
|||
Amortization of benefits liability
|
|
2
|
|
|
1
|
|
|
3
|
|
|||
Income tax provision on pension and other post-retirement
benefits liability
|
|
(7
|
)
|
|
(24
|
)
|
|
(6
|
)
|
|||
Foreign currency translation adjustments
|
|
|
|
|
|
|
||||||
Foreign currency translation
|
|
124
|
|
|
(34
|
)
|
|
(60
|
)
|
|||
Income tax provision on foreign currency translation
|
|
(5
|
)
|
|
—
|
|
|
—
|
|
|||
Available-for-sale investments
|
|
|
|
|
|
|
||||||
Unrealized holding gains (losses) on investments
|
|
—
|
|
|
62
|
|
|
(4
|
)
|
|||
Reclassification of net realized gains to net income
|
|
—
|
|
|
(54
|
)
|
|
(4
|
)
|
|||
Income tax benefit (provision) on available-for-sale investments
|
|
—
|
|
|
(3
|
)
|
|
3
|
|
|||
Other comprehensive income (loss)
|
|
133
|
|
|
8
|
|
|
(50
|
)
|
|||
Comprehensive income
|
|
1,472
|
|
|
428
|
|
|
615
|
|
|||
Comprehensive income attributable to noncontrolling interests,
net of tax of $1, $0 and $0 for 2017, 2016 and 2015, respectively
|
|
40
|
|
|
21
|
|
|
19
|
|
|||
Comprehensive income attributable to Westlake Chemical Corporation
|
|
$
|
1,432
|
|
|
$
|
407
|
|
|
$
|
596
|
|
|
|
Common Stock
|
|
Common Stock,
Held in Treasury
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||
|
|
Number of
Shares
|
|
Amount
|
|
Number of
Shares
|
|
At Cost
|
|
Additional
Paid-in
Capital
|
|
Retained
Earnings
|
|
Accumulated Other Comprehensive
Income (Loss)
|
|
Noncontrolling Interests
|
|
Total
|
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
|
|
(in millions of dollars, except share amounts)
|
||||||||||||||||||||||||||||||||
Balances at December 31, 2014
|
|
134,679,064
|
|
|
$
|
1
|
|
|
1,787,546
|
|
|
$
|
(96
|
)
|
|
$
|
530
|
|
|
$
|
2,556
|
|
|
$
|
(79
|
)
|
|
$
|
290
|
|
|
$
|
3,202
|
|
Net income
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
646
|
|
|
—
|
|
|
19
|
|
|
665
|
|
|||||||
Other comprehensive
income (loss)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(50
|
)
|
|
—
|
|
|
(50
|
)
|
|||||||
Common stock
repurchased
|
|
—
|
|
|
—
|
|
|
2,701,937
|
|
|
(163
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(163
|
)
|
|||||||
Shares issued—stock-
based compensation
|
|
(15,820
|
)
|
|
—
|
|
|
(44,585
|
)
|
|
1
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1
|
|
|||||||
Stock-based compensation,
net of tax on stock
options exercised
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
12
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
12
|
|
|||||||
Dividends declared
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(92
|
)
|
|
—
|
|
|
—
|
|
|
(92
|
)
|
|||||||
Distributions to
noncontrolling interests
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(15
|
)
|
|
(15
|
)
|
|||||||
Noncontrolling interest in
acquired business
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
2
|
|
|
2
|
|
|||||||
Balances at December 31, 2015
|
|
134,663,244
|
|
|
1
|
|
|
4,444,898
|
|
|
(258
|
)
|
|
542
|
|
|
3,110
|
|
|
(129
|
)
|
|
296
|
|
|
3,562
|
|
|||||||
Net income
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
399
|
|
|
—
|
|
|
21
|
|
|
420
|
|
|||||||
Other comprehensive
income
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
8
|
|
|
—
|
|
|
8
|
|
|||||||
Common stock
repurchased
|
|
—
|
|
|
—
|
|
|
1,511,109
|
|
|
(67
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(67
|
)
|
|||||||
Shares issued—stock-
based compensation
|
|
(11,864
|
)
|
|
—
|
|
|
(117,019
|
)
|
|
3
|
|
|
5
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
8
|
|
|||||||
Stock-based compensation,
net of tax on stock
options exercised
|
|
—
|
|
|
—
|
|
|
(112,611
|
)
|
|
3
|
|
|
4
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
7
|
|
|||||||
Dividends declared
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(97
|
)
|
|
—
|
|
|
—
|
|
|
(97
|
)
|
|||||||
Distributions to
noncontrolling interests
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(17
|
)
|
|
(17
|
)
|
|||||||
Noncontrolling interest in
acquired business
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
68
|
|
|
68
|
|
|||||||
Balances at December 31, 2016
|
|
134,651,380
|
|
|
1
|
|
|
5,726,377
|
|
|
(319
|
)
|
|
551
|
|
|
3,412
|
|
|
(121
|
)
|
|
368
|
|
|
3,892
|
|
|||||||
Net income
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1,304
|
|
|
—
|
|
|
35
|
|
|
1,339
|
|
|||||||
Other comprehensive
income
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
128
|
|
|
5
|
|
|
133
|
|
|||||||
Shares issued—stock-
based compensation
|
|
—
|
|
|
—
|
|
|
(493,502
|
)
|
|
17
|
|
|
(6
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
11
|
|
|||||||
Stock-based compensation,
net of tax on stock
options exercised
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
14
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
14
|
|
|||||||
Dividends declared
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(103
|
)
|
|
—
|
|
|
—
|
|
|
(103
|
)
|
|||||||
Distributions to
noncontrolling interests
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(28
|
)
|
|
(28
|
)
|
|||||||
Issuance of Westlake
Chemical Partners LP
common units
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(4
|
)
|
|
—
|
|
|
—
|
|
|
115
|
|
|
111
|
|
|||||||
Balances at December 31, 2017
|
|
134,651,380
|
|
|
$
|
1
|
|
|
5,232,875
|
|
|
$
|
(302
|
)
|
|
$
|
555
|
|
|
$
|
4,613
|
|
|
$
|
7
|
|
|
$
|
495
|
|
|
$
|
5,369
|
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2017
|
|
2016
|
|
2015
|
||||||
|
|
|
|
|
|
|
||||||
|
|
(in millions of dollars)
|
||||||||||
Cash flows from operating activities
|
|
|
|
|
|
|
||||||
Net income
|
|
$
|
1,339
|
|
|
$
|
420
|
|
|
$
|
665
|
|
Adjustments to reconcile net income to net cash provided by operating
activities
|
|
|
|
|
|
|
||||||
Depreciation and amortization
|
|
601
|
|
|
378
|
|
|
246
|
|
|||
Stock-based compensation expense
|
|
23
|
|
|
14
|
|
|
10
|
|
|||
Gains realized on previously held shares of Axiall common stock and
from sales of securities
|
|
—
|
|
|
(54
|
)
|
|
(4
|
)
|
|||
Gain on acquisition, net of loss on the fair value remeasurement
of preexisting equity interest
|
|
—
|
|
|
—
|
|
|
(21
|
)
|
|||
Loss from disposition of property, plant and equipment
|
|
22
|
|
|
9
|
|
|
11
|
|
|||
Deferred income taxes
|
|
(534
|
)
|
|
101
|
|
|
40
|
|
|||
Other losses (gains), net
|
|
(3
|
)
|
|
5
|
|
|
6
|
|
|||
Changes in operating assets and liabilities, net of effect of business
acquisitions
|
|
|
|
|
|
|
||||||
Accounts receivable
|
|
(40
|
)
|
|
50
|
|
|
63
|
|
|||
Inventories
|
|
(32
|
)
|
|
(62
|
)
|
|
99
|
|
|||
Prepaid expenses and other current assets
|
|
26
|
|
|
11
|
|
|
(4
|
)
|
|||
Accounts payable
|
|
86
|
|
|
12
|
|
|
(22
|
)
|
|||
Accrued liabilities
|
|
115
|
|
|
48
|
|
|
(8
|
)
|
|||
Other, net
|
|
(65
|
)
|
|
(98
|
)
|
|
(2
|
)
|
|||
Net cash provided by operating activities
|
|
1,538
|
|
|
834
|
|
|
1,079
|
|
|||
Cash flows from investing activities
|
|
|
|
|
|
|
||||||
Acquisition of business, net of cash acquired
|
|
(13
|
)
|
|
(2,438
|
)
|
|
16
|
|
|||
Additions to property, plant and equipment
|
|
(577
|
)
|
|
(629
|
)
|
|
(491
|
)
|
|||
Additions to cost method investment
|
|
(66
|
)
|
|
(17
|
)
|
|
—
|
|
|||
Proceeds from disposition of equity method investment
|
|
—
|
|
|
—
|
|
|
28
|
|
|||
Proceeds from sales and maturities of securities
|
|
—
|
|
|
663
|
|
|
49
|
|
|||
Purchase of securities
|
|
—
|
|
|
(138
|
)
|
|
(605
|
)
|
|||
Other
|
|
4
|
|
|
(4
|
)
|
|
(3
|
)
|
|||
Net cash used for investing activities
|
|
(652
|
)
|
|
(2,563
|
)
|
|
(1,006
|
)
|
|||
Cash flows from financing activities
|
|
|
|
|
|
|
||||||
Debt issuance costs
|
|
(6
|
)
|
|
(36
|
)
|
|
—
|
|
|||
Dividends paid
|
|
(103
|
)
|
|
(97
|
)
|
|
(92
|
)
|
|||
Distributions to noncontrolling interests
|
|
(28
|
)
|
|
(17
|
)
|
|
(15
|
)
|
|||
Proceeds from debt issuance and drawdown of revolver
|
|
233
|
|
|
608
|
|
|
53
|
|
|||
Net proceeds from issuance of Westlake Chemical Partners LP
common units
|
|
111
|
|
|
—
|
|
|
—
|
|
|||
Proceeds from senior notes issuance
|
|
745
|
|
|
1,429
|
|
|
—
|
|
|||
Repayment of term loan
|
|
(150
|
)
|
|
—
|
|
|
—
|
|
|||
Restricted cash associated with term loan
|
|
154
|
|
|
(154
|
)
|
|
—
|
|
|||
Repayment of revolver
|
|
(550
|
)
|
|
(125
|
)
|
|
—
|
|
|||
Repayment of notes payable
|
|
(257
|
)
|
|
(13
|
)
|
|
(74
|
)
|
|||
Repurchase of common stock for treasury
|
|
—
|
|
|
(67
|
)
|
|
(163
|
)
|
|||
Other
|
|
11
|
|
|
5
|
|
|
4
|
|
|||
Net cash provided by (used for) financing activities
|
|
160
|
|
|
1,533
|
|
|
(287
|
)
|
|||
Effect of exchange rate changes on cash and cash equivalents
|
|
26
|
|
|
(8
|
)
|
|
(4
|
)
|
|||
Net increase (decrease) in cash and cash equivalents
|
|
1,072
|
|
|
(204
|
)
|
|
(218
|
)
|
|||
Cash and cash equivalents at beginning of the year
|
|
459
|
|
|
663
|
|
|
881
|
|
|||
Cash and cash equivalents at end of the year
|
|
$
|
1,531
|
|
|
$
|
459
|
|
|
$
|
663
|
|
Classification
|
|
Years
|
Buildings and improvements
|
40
|
|
Plant and equipment
|
25
|
|
Ethylene pipeline
|
35
|
|
Other
|
3-15
|
|
|
Final Purchase Consideration as of August 31, 2016
|
||
Closing stock purchase:
|
|
|
||
Offer per share
|
|
$
|
33.00
|
|
Multiplied by number of shares outstanding at acquisition (in thousands of shares)
|
|
67,277
|
|
|
Fair value of Axiall shares outstanding purchased by the Company
|
|
2,220
|
|
|
Plus:
|
|
|
||
Axiall debt repaid at acquisition
|
|
247
|
|
|
Seller's transaction costs paid by the Company
(1)
|
|
48
|
|
|
Total fair value of consideration transferred
|
|
2,515
|
|
|
|
|
|
||
Fair value of Axiall share-based awards attributed to pre-combination service
(2)
|
|
12
|
|
|
Additional settlement value of shares acquired
|
|
13
|
|
|
Purchase consideration
|
|
2,540
|
|
|
|
|
|
||
Fair value of previously held equity interest in Axiall
(3)
|
|
102
|
|
|
Total fair value allocated to net assets acquired
|
|
$
|
2,642
|
|
(1)
|
Transactions costs incurred by the seller included legal and advisory costs incurred for the benefit of Axiall's former shareholders and board of directors to evaluate the Company's initial Merger proposals, explore strategic alternatives and negotiate the purchase price.
|
(2)
|
The fair value of share-based awards attributable to pre-combination service includes the ratio of the pre-combination service performed to the original service period of the Axiall restricted share units and options, including related dividend equivalent rights.
|
(3)
|
Prior to the Merger, the Company owned
3.1 million
shares in Axiall. The investment in Axiall was carried at estimated fair value with unrealized gains recorded as a component of accumulated other comprehensive loss in the consolidated balance sheet. The Company recognized a
$49
gain for the investment in other income, net in the consolidated statements of operations upon gaining control.
|
|
|
Net Assets Acquired as of August 31, 2016
|
||
Cash
|
|
$
|
88
|
|
Accounts receivable
(1)
|
|
422
|
|
|
Income tax receivable
|
|
51
|
|
|
Inventories
(2)
|
|
349
|
|
|
Prepaid expenses and other current assets
|
|
56
|
|
|
Property, plant and equipment
(2)
|
|
2,942
|
|
|
Customer relationships (weighted average lives of 9.8 years)
(3)
|
|
670
|
|
|
Other intangible assets:
|
|
|
||
Trade name (weighted average lives of 6.8 years)
|
|
50
|
|
|
Technology (weighted average lives of 5.4 years)
|
|
42
|
|
|
Supply contracts and leases (weighted average lives of 6.3 years)
|
|
27
|
|
|
Other assets
|
|
94
|
|
|
Total assets acquired
|
|
$
|
4,791
|
|
Accounts and notes payable
|
|
254
|
|
|
Interest payable
|
|
8
|
|
|
Income tax payable
|
|
2
|
|
|
Accrued compensation
|
|
44
|
|
|
Accrued liabilities
|
|
154
|
|
|
Deferred income taxes
(4)
|
|
958
|
|
|
Tax reserve non-current
|
|
3
|
|
|
Pension and other post-retirement obligations
|
|
311
|
|
|
Other liabilities
|
|
102
|
|
|
Long-term debt
|
|
1,187
|
|
|
Total liabilities assumed
|
|
$
|
3,023
|
|
Total identifiable net assets acquired
|
|
$
|
1,768
|
|
Noncontrolling interest
|
|
(68
|
)
|
|
Goodwill
|
|
942
|
|
|
Total fair value allocated to net assets acquired
|
|
$
|
2,642
|
|
(1)
|
The fair value of accounts receivable acquired was
$422
, with the gross contractual amount being
$435
. The Company expects
$13
to be uncollectible.
|
(2)
|
The Company obtained additional information related to its inventories and property, plant and equipment, which led to an increase in inventories of
$43
, a decrease in property plant and equipment of
$193
and a corresponding increase in goodwill of
$150
compared to the estimated fair values included in the 2016 Form 10-K.
|
(3)
|
The Company obtained additional information related to its customer relationship balances which led to an increase in customer relationships of
$80
and a corresponding decrease in goodwill compared to the estimated fair values included in the 2016 Form 10-K.
|
(4)
|
Decreases in the estimated fair values of identified assets acquired led to a decrease in deferred income taxes of
$27
compared to the estimated fair values included in the 2016 Form 10-K.
|
|
|
Pro Forma
|
||||||
|
|
Year Ended December 31,
|
||||||
|
|
2016
|
|
2015
|
||||
Net sales
|
|
$
|
7,081
|
|
|
$
|
7,793
|
|
|
|
|
|
|
||||
Net income
(1)
|
|
$
|
397
|
|
|
$
|
663
|
|
Net income (loss) attributable to noncontrolling interest
|
|
23
|
|
|
(2
|
)
|
||
Net income attributable to Westlake Chemical Corporation
(1)
|
|
$
|
374
|
|
|
$
|
665
|
|
Earnings per common share attributable to Westlake Chemical Corporation:
|
|
|
|
|
||||
Basic
|
|
$
|
2.88
|
|
|
$
|
5.02
|
|
Diluted
|
|
$
|
2.86
|
|
|
$
|
5.00
|
|
(1)
|
The 2016 pro forma net income amounts include Axiall's historical charges recorded during the eight-month period prior to the closing of the Merger for (1) divestitures; (2) restructuring; and (3) legal and settlement claims, net, of
$27
,
$23
and
$23
, respectively. These amounts have not been eliminated for pro forma results because they do not relate to nonrecurring transaction-specific costs related to the Merger.
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2017
|
|
2016
|
|
2015
|
||||||
Proceeds from sales and maturities of securities
|
|
$
|
—
|
|
|
$
|
663
|
|
|
$
|
49
|
|
Gross realized gains
|
|
—
|
|
|
54
|
|
|
4
|
|
|
|
2017
|
|
2016
|
||||
Trade customers
|
|
$
|
974
|
|
|
$
|
820
|
|
Affiliates
|
|
9
|
|
|
8
|
|
||
Allowance for doubtful accounts
|
|
(22
|
)
|
|
(18
|
)
|
||
|
|
961
|
|
|
810
|
|
||
Federal and state taxes
|
|
7
|
|
|
90
|
|
||
Other
|
|
33
|
|
|
39
|
|
||
Accounts receivable, net
|
|
$
|
1,001
|
|
|
$
|
939
|
|
|
|
2017
|
|
2016
|
||||
Finished products
|
|
$
|
549
|
|
|
$
|
501
|
|
Feedstock, additives and chemicals
|
|
221
|
|
|
217
|
|
||
Materials and supplies
|
|
130
|
|
|
83
|
|
||
Inventories
|
|
$
|
900
|
|
|
$
|
801
|
|
|
|
2017
|
|
2016
|
||||
Land
|
|
$
|
198
|
|
|
$
|
194
|
|
Buildings and improvements
|
|
495
|
|
|
465
|
|
||
Plant and equipment
|
|
7,281
|
|
|
6,914
|
|
||
Other
|
|
388
|
|
|
377
|
|
||
|
|
8,362
|
|
|
7,950
|
|
||
Less: Accumulated depreciation
|
|
(2,338
|
)
|
|
(1,919
|
)
|
||
|
|
6,024
|
|
|
6,031
|
|
||
Construction in progress
|
|
388
|
|
|
389
|
|
||
Property, plant and equipment, net
|
|
$
|
6,412
|
|
|
$
|
6,420
|
|
|
|
Olefins Segment
|
|
Vinyls Segment
|
|
Total
|
||||||
Balance at December 31, 2015
|
|
$
|
30
|
|
|
$
|
32
|
|
|
$
|
62
|
|
Goodwill acquired during the year
|
|
—
|
|
|
888
|
|
|
888
|
|
|||
Effects of changes in foreign exchange rates
|
|
—
|
|
|
(3
|
)
|
|
(3
|
)
|
|||
Balance at December 31, 2016
|
|
30
|
|
|
917
|
|
|
947
|
|
|||
Measurement period adjustment
|
|
—
|
|
|
55
|
|
|
55
|
|
|||
Effects of changes in foreign exchange rates
|
|
—
|
|
|
10
|
|
|
10
|
|
|||
Balance at December 31, 2017
|
|
$
|
30
|
|
|
$
|
982
|
|
|
$
|
1,012
|
|
|
|
2017
|
|
2016
|
|
Weighted
Average
Life
|
||||||||||||||||||||
|
|
Cost
|
|
Accumulated
Amortization
|
|
Net
|
|
Cost
|
|
Accumulated
Amortization
|
|
Net
|
|
|||||||||||||
Customer relationships
|
|
$
|
754
|
|
|
$
|
(138
|
)
|
|
$
|
616
|
|
|
$
|
662
|
|
|
$
|
(51
|
)
|
|
$
|
611
|
|
|
10
|
Other intangible assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Licenses and
intellectual property
|
|
124
|
|
|
(55
|
)
|
|
69
|
|
|
121
|
|
|
(44
|
)
|
|
77
|
|
|
13
|
||||||
Trademarks
|
|
93
|
|
|
(17
|
)
|
|
76
|
|
|
88
|
|
|
(7
|
)
|
|
81
|
|
|
13
|
||||||
Other
|
|
31
|
|
|
(15
|
)
|
|
16
|
|
|
31
|
|
|
(13
|
)
|
|
18
|
|
|
12
|
||||||
Total other intangible
assets
|
|
$
|
248
|
|
|
$
|
(87
|
)
|
|
$
|
161
|
|
|
$
|
240
|
|
|
$
|
(64
|
)
|
|
$
|
176
|
|
|
|
|
|
December 31, 2017
|
|
December 31, 2016
|
||||||||||||||||||||
|
|
Principal Amount
|
|
Unamortized Premium, Discount and Debt Issuance Costs
|
|
Net Long-Term Debt
|
|
Principal Amount
|
|
Unamortized Premium, Discount and Debt Issuance Costs
|
|
Net Long-Term Debt
|
||||||||||||
Revolving credit facility
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
325
|
|
|
$
|
—
|
|
|
$
|
325
|
|
4.625% senior notes due 2021 (the
"4.625% Westlake 2021 Senior Notes")
|
|
625
|
|
|
20
|
|
|
645
|
|
|
625
|
|
|
27
|
|
|
652
|
|
||||||
4.625% senior notes due 2021
(the "4.625% Subsidiary 2021 Senior
Notes")
|
|
63
|
|
|
2
|
|
|
65
|
|
|
63
|
|
|
3
|
|
|
66
|
|
||||||
3.60% senior notes due 2022 (the "3.60%
2022 Senior Notes")
|
|
250
|
|
|
(1
|
)
|
|
249
|
|
|
250
|
|
|
(2
|
)
|
|
248
|
|
||||||
4.875% senior notes due 2023 (the
"4.875% Westlake 2023 Senior Notes")
|
|
434
|
|
|
11
|
|
|
445
|
|
|
434
|
|
|
13
|
|
|
447
|
|
||||||
4.875% senior notes due 2023
(the "4.875% Subsidiary 2023 Senior
Notes")
|
|
16
|
|
|
—
|
|
|
16
|
|
|
16
|
|
|
1
|
|
|
17
|
|
||||||
3.60% senior notes due 2026
(the "3.60% 2026 Senior Notes")
|
|
750
|
|
|
(10
|
)
|
|
740
|
|
|
750
|
|
|
(11
|
)
|
|
739
|
|
||||||
Loan related to tax-exempt waste disposal
revenue bonds due 2027
|
|
11
|
|
|
—
|
|
|
11
|
|
|
11
|
|
|
—
|
|
|
11
|
|
||||||
6 ½% senior notes due 2029 (the "6 ½%
2029 GO Zone Senior Notes")
|
|
100
|
|
|
(1
|
)
|
|
99
|
|
|
100
|
|
|
(1
|
)
|
|
99
|
|
||||||
6 ¾% senior notes due 2032 (the "6 ¾%
2032 GO Zone Senior Notes")
|
|
—
|
|
|
—
|
|
|
—
|
|
|
250
|
|
|
(2
|
)
|
|
248
|
|
||||||
6 ½% senior notes due 2035 (the "6 ½%
2035 GO Zone Senior Notes") |
|
89
|
|
|
(1
|
)
|
|
88
|
|
|
89
|
|
|
(1
|
)
|
|
88
|
|
||||||
6 ½% senior notes due 2035 (the "6 ½%
2035 IKE Zone Senior Notes") |
|
65
|
|
|
—
|
|
|
65
|
|
|
65
|
|
|
—
|
|
|
65
|
|
||||||
5.0% senior notes due 2046 (the "5.0%
2046 Senior Notes")
|
|
700
|
|
|
(25
|
)
|
|
675
|
|
|
700
|
|
|
(26
|
)
|
|
674
|
|
||||||
4.375% senior notes due 2047 (the
"4.375% 2047 Senior Notes")
|
|
500
|
|
|
(9
|
)
|
|
491
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
3.50% senior notes due 2032 (the "3.50%
2032 Go Zone Refunding Senior
Notes")
|
|
250
|
|
|
(2
|
)
|
|
248
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
Total long-term debt
|
|
3,853
|
|
|
(16
|
)
|
|
3,837
|
|
|
3,678
|
|
|
1
|
|
|
3,679
|
|
||||||
Less: Current portion - 4.625%
Westlake 2021 Senior Notes and 4.625%
Subsidiary 2021 Senior Notes
|
|
688
|
|
|
22
|
|
|
710
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
Long-Term Debt, net of current portion
|
|
$
|
3,165
|
|
|
$
|
(38
|
)
|
|
$
|
3,127
|
|
|
$
|
3,678
|
|
|
$
|
1
|
|
|
$
|
3,679
|
|
|
|
Benefits
Liability,
Net of Tax
|
|
Cumulative
Foreign
Currency
Exchange
|
|
Net Unrealized
Holding Gains
on Investments,
Net of Tax
|
|
Total
|
||||||||
Balances at December 31, 2015
|
|
$
|
(8
|
)
|
|
$
|
(116
|
)
|
|
$
|
(5
|
)
|
|
$
|
(129
|
)
|
Other comprehensive income (loss) before
reclassifications
|
|
36
|
|
|
(34
|
)
|
|
57
|
|
|
59
|
|
||||
Amounts reclassified from accumulated other
comprehensive income (loss)
|
|
1
|
|
|
—
|
|
|
(52
|
)
|
|
(51
|
)
|
||||
Net other comprehensive income (loss) attributable to
Westlake Chemical Corporation
|
|
37
|
|
|
(34
|
)
|
|
5
|
|
|
8
|
|
||||
Balances at December 31, 2016
|
|
29
|
|
|
(150
|
)
|
|
—
|
|
|
(121
|
)
|
||||
Other comprehensive income before
reclassifications
|
|
12
|
|
|
114
|
|
|
—
|
|
|
126
|
|
||||
Amounts reclassified from accumulated other
comprehensive income (loss)
|
|
2
|
|
|
—
|
|
|
—
|
|
|
2
|
|
||||
Net other comprehensive income attributable to
Westlake Chemical Corporation
|
|
14
|
|
|
114
|
|
|
—
|
|
|
128
|
|
||||
Balances at December 31, 2017
|
|
$
|
43
|
|
|
$
|
(36
|
)
|
|
$
|
—
|
|
|
$
|
7
|
|
Details about Accumulated Other
Comprehensive Income (Loss) Components
|
|
Location of Reclassification
(Income (Expense)) in
Consolidated Statements
of Operations
|
|
Year Ended December 31,
|
||||||||||
|
2017
|
|
2016
|
|
2015
|
|||||||||
Amortization of pension and other
post-retirement items
|
|
|
|
|
|
|
|
|
||||||
Net loss
|
|
(1)
|
|
$
|
(2
|
)
|
|
$
|
(2
|
)
|
|
$
|
(3
|
)
|
|
|
|
|
(2
|
)
|
|
(2
|
)
|
|
(3
|
)
|
|||
|
|
Benefit from income taxes
|
|
—
|
|
|
1
|
|
|
1
|
|
|||
|
|
|
|
(2
|
)
|
|
(1
|
)
|
|
(2
|
)
|
|||
Net unrealized gains on available-for-
sale investments
|
|
|
|
|
|
|
|
|
||||||
Realized gain on available-
for-sale investments
|
|
Other income, net
|
|
—
|
|
|
54
|
|
|
4
|
|
|||
|
|
Provision for income taxes
|
|
—
|
|
|
(2
|
)
|
|
(1
|
)
|
|||
|
|
|
|
—
|
|
|
52
|
|
|
3
|
|
|||
Total reclassifications for the period
|
|
|
|
$
|
(2
|
)
|
|
$
|
51
|
|
|
$
|
1
|
|
(1)
|
These accumulated other comprehensive loss components are included in the computation of net periodic benefit cost. For additional information, see Note 12.
|
|
|
2017
|
|
2016
|
||||||||||||
|
|
U.S. Plans
|
|
Non-U.S. Plans
|
|
U.S. Plans
|
|
Non-U.S. Plans
|
||||||||
Change in benefit obligation
|
|
|
|
|
|
|
|
|
||||||||
Benefit obligation, beginning of year
|
|
$
|
799
|
|
|
$
|
125
|
|
|
$
|
62
|
|
|
$
|
95
|
|
Benefit obligation assumed with acquisition
|
|
—
|
|
|
—
|
|
|
818
|
|
|
21
|
|
||||
Service cost
|
|
3
|
|
|
2
|
|
|
1
|
|
|
1
|
|
||||
Interest cost
|
|
25
|
|
|
3
|
|
|
9
|
|
|
2
|
|
||||
Actuarial loss (gain)
|
|
41
|
|
|
—
|
|
|
(74
|
)
|
|
13
|
|
||||
Benefits paid
|
|
(45
|
)
|
|
(3
|
)
|
|
(17
|
)
|
|
(3
|
)
|
||||
Settlements
|
|
(16
|
)
|
|
(1
|
)
|
|
—
|
|
|
—
|
|
||||
Foreign exchange effects
|
|
—
|
|
|
16
|
|
|
—
|
|
|
(4
|
)
|
||||
Benefit obligation, end of year
|
|
$
|
807
|
|
|
$
|
142
|
|
|
$
|
799
|
|
|
$
|
125
|
|
|
|
|
|
|
|
|
|
|
||||||||
Change in plan assets
|
|
|
|
|
|
|
|
|
||||||||
Fair value of plan assets, beginning of year
|
|
$
|
614
|
|
|
$
|
16
|
|
|
$
|
51
|
|
|
$
|
—
|
|
Acquisition
|
|
—
|
|
|
—
|
|
|
576
|
|
|
16
|
|
||||
Actual return
|
|
97
|
|
|
1
|
|
|
7
|
|
|
—
|
|
||||
Employer contribution
|
|
2
|
|
|
1
|
|
|
—
|
|
|
3
|
|
||||
Benefits paid
|
|
(45
|
)
|
|
—
|
|
|
(17
|
)
|
|
(3
|
)
|
||||
Administrative expenses paid
|
|
(2
|
)
|
|
—
|
|
|
(3
|
)
|
|
—
|
|
||||
Settlements
|
|
(16
|
)
|
|
(1
|
)
|
|
—
|
|
|
—
|
|
||||
Foreign exchange effects
|
|
—
|
|
|
1
|
|
|
—
|
|
|
—
|
|
||||
Fair value of plan assets, end of year
|
|
$
|
650
|
|
|
$
|
18
|
|
|
$
|
614
|
|
|
$
|
16
|
|
Funded status, end of year
|
|
$
|
(157
|
)
|
|
$
|
(124
|
)
|
|
$
|
(185
|
)
|
|
$
|
(109
|
)
|
|
|
2017
|
|
2016
|
||||||||||||
|
|
U.S. Plans
|
|
Non-U.S. Plans
|
|
U.S. Plans
|
|
Non-U.S. Plans
|
||||||||
Amounts recognized in the consolidated
balance sheet at December 31
|
|
|
|
|
|
|
|
|
||||||||
Current liabilities
|
|
$
|
(2
|
)
|
|
$
|
(3
|
)
|
|
$
|
(2
|
)
|
|
$
|
(2
|
)
|
Noncurrent liabilities
|
|
(155
|
)
|
|
(121
|
)
|
|
(183
|
)
|
|
(107
|
)
|
||||
Net amount recognized
|
|
$
|
(157
|
)
|
|
$
|
(124
|
)
|
|
$
|
(185
|
)
|
|
$
|
(109
|
)
|
|
|
2017
|
|
2016
|
||||||||||||
|
|
U.S. Plans
|
|
Non-U.S. Plans
|
|
U.S. Plans
|
|
Non-U.S. Plans
|
||||||||
Amounts recognized in accumulated other
comprehensive income (loss)
|
|
|
|
|
|
|
|
|
||||||||
Net loss (gain)
|
|
$
|
(71
|
)
|
|
$
|
9
|
|
|
$
|
(53
|
)
|
|
$
|
8
|
|
Total before tax
(1)
|
|
$
|
(71
|
)
|
|
$
|
9
|
|
|
$
|
(53
|
)
|
|
$
|
8
|
|
(1)
|
After-tax totals for pension benefits were
$43
and
$30
for
2017
and
2016
, respectively, and are reflected in stockholders' equity as accumulated other comprehensive income.
|
|
|
2017
|
|
2016
|
||||||||||||
|
|
U.S. Plans
|
|
Non-U.S. Plans
|
|
U.S. Plans
|
|
Non-U.S. Plans
|
||||||||
Information for pension plans with an accumulated
benefit obligation in excess of plan assets
|
|
|
|
|
|
|
|
|
||||||||
Projected benefit obligation
|
|
$
|
(807
|
)
|
|
$
|
(128
|
)
|
|
$
|
(799
|
)
|
|
$
|
(113
|
)
|
Accumulated benefit obligation
|
|
(807
|
)
|
|
(126
|
)
|
|
(799
|
)
|
|
(110
|
)
|
||||
Fair value of plan assets
|
|
650
|
|
|
5
|
|
|
614
|
|
|
5
|
|
|
|
Year Ended December 31,
|
||||||||||||||||||||||
|
|
2017
|
|
2016
|
|
2015
|
||||||||||||||||||
|
|
U.S.
Plans
|
|
Non-U.S.
Plans
|
|
U.S.
Plans
|
|
Non-U.S.
Plans
|
|
U.S.
Plans
|
|
Non-U.S.
Plans
|
||||||||||||
Components of net periodic benefit cost
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Service cost
|
|
$
|
3
|
|
|
$
|
2
|
|
|
$
|
1
|
|
|
$
|
2
|
|
|
$
|
—
|
|
|
$
|
2
|
|
Administrative expenses
|
|
2
|
|
|
—
|
|
|
3
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
Interest cost
|
|
25
|
|
|
2
|
|
|
9
|
|
|
2
|
|
|
2
|
|
|
2
|
|
||||||
Expected return on plan assets
|
|
(40
|
)
|
|
(1
|
)
|
|
(15
|
)
|
|
—
|
|
|
(3
|
)
|
|
—
|
|
||||||
Net amortization
|
|
1
|
|
|
1
|
|
|
1
|
|
|
—
|
|
|
1
|
|
|
1
|
|
||||||
Settlement benefits
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1
|
|
|
—
|
|
||||||
Net periodic benefit cost (gain)
|
|
$
|
(9
|
)
|
|
$
|
4
|
|
|
$
|
(1
|
)
|
|
$
|
4
|
|
|
$
|
1
|
|
|
$
|
5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Other changes in plan assets and benefit
obligation recognized in other
comprehensive income (OCI)
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Net loss (gain) emerging
|
|
$
|
(18
|
)
|
|
$
|
—
|
|
|
$
|
(67
|
)
|
|
$
|
13
|
|
|
$
|
1
|
|
|
$
|
(17
|
)
|
Amortization of net loss
|
|
(1
|
)
|
|
(1
|
)
|
|
(1
|
)
|
|
—
|
|
|
(2
|
)
|
|
(1
|
)
|
||||||
Total recognized in OCI
|
|
$
|
(19
|
)
|
|
$
|
(1
|
)
|
|
$
|
(68
|
)
|
|
$
|
13
|
|
|
$
|
(1
|
)
|
|
$
|
(18
|
)
|
Total net periodic benefit cost and OCI
|
|
$
|
(28
|
)
|
|
$
|
3
|
|
|
$
|
(69
|
)
|
|
$
|
17
|
|
|
$
|
—
|
|
|
$
|
(13
|
)
|
|
|
2017
|
|
2016
|
|
2015
|
||||||||||||
|
|
U.S.
Plans
|
|
Non-U.S.
Plans
|
|
U.S.
Plans
|
|
Non-U.S.
Plans
|
|
U.S.
Plans
|
|
Non-U.S.
Plans
|
||||||
Weighted average assumptions used to
determine benefit obligations at
December 31
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Discount rate
|
|
3.4
|
%
|
|
1.8
|
%
|
|
3.8
|
%
|
|
1.8
|
%
|
|
4.0
|
%
|
|
2.4
|
%
|
Rate of compensation increase
|
|
—
|
%
|
|
2.6
|
%
|
|
—
|
%
|
|
2.6
|
%
|
|
—
|
%
|
|
2.5
|
%
|
Weighted average assumptions used to
determine net periodic benefit costs for
years ended December 31
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Discount rate for benefit obligations
|
|
3.8
|
%
|
|
1.8
|
%
|
|
3.2
|
%
|
|
2.4
|
%
|
|
3.5
|
%
|
|
1.9
|
%
|
Discount rate for service cost
|
|
4.1
|
%
|
|
1.9
|
%
|
|
3.4
|
%
|
|
2.4
|
%
|
|
—
|
%
|
|
—
|
%
|
Discount rate for interest cost
|
|
3.2
|
%
|
|
2.0
|
%
|
|
2.9
|
%
|
|
2.4
|
%
|
|
—
|
%
|
|
—
|
%
|
Expected return on plan assets
|
|
6.8
|
%
|
|
3.8
|
%
|
|
6.8
|
%
|
|
4.6
|
%
|
|
7.0
|
%
|
|
—
|
%
|
Rate of compensation increase
|
|
N/A
|
|
|
2.6
|
%
|
|
—
|
%
|
|
2.6
|
%
|
|
—
|
%
|
|
2.5
|
%
|
|
|
2017
|
||||||||||||||||||||||
|
|
U.S. Plans
|
|
Non U.S. Plans
|
||||||||||||||||||||
|
|
Level 1
|
|
Level 2
|
|
Total
|
|
Level 1
|
|
Level 2
|
|
Total
|
||||||||||||
Cash and common stock:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Cash and cash equivalents
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
5
|
|
|
$
|
—
|
|
|
$
|
5
|
|
Common stock
|
|
21
|
|
|
—
|
|
|
21
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
Collective investment trust and
mutual funds—Equity securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Large-cap funds
(1)
|
|
49
|
|
|
173
|
|
|
222
|
|
|
—
|
|
|
2
|
|
|
2
|
|
||||||
Small-cap funds
(2)
|
|
9
|
|
|
25
|
|
|
34
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
International funds
(3)
|
|
69
|
|
|
50
|
|
|
119
|
|
|
—
|
|
|
5
|
|
|
5
|
|
||||||
Collective investment trust and mutual
funds—Fixed income:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Bond funds
(4)
|
|
116
|
|
|
125
|
|
|
241
|
|
|
—
|
|
|
6
|
|
|
6
|
|
||||||
Short-term investment funds
|
|
—
|
|
|
13
|
|
|
13
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
|
|
$
|
264
|
|
|
$
|
386
|
|
|
$
|
650
|
|
|
$
|
5
|
|
|
$
|
13
|
|
|
$
|
18
|
|
|
|
2016
|
||||||||||||||||||||||
|
|
U.S. Plans
|
|
Non U.S. Plans
|
||||||||||||||||||||
|
|
Level 1
|
|
Level 2
|
|
Total
|
|
Level 1
|
|
Level 2
|
|
Total
|
||||||||||||
Cash and common stock:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Cash and cash equivalents
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
5
|
|
|
$
|
—
|
|
|
$
|
5
|
|
Common stock
|
|
17
|
|
|
—
|
|
|
17
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
Collective investment trust and
mutual funds—Equity securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Large-cap funds
(1)
|
|
50
|
|
|
167
|
|
|
217
|
|
|
—
|
|
|
2
|
|
|
2
|
|
||||||
Small-cap funds
(2)
|
|
8
|
|
|
23
|
|
|
31
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
International funds
(3)
|
|
53
|
|
|
54
|
|
|
107
|
|
|
—
|
|
|
4
|
|
|
4
|
|
||||||
Collective investment trust and mutual
funds—Fixed income:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Bond funds
(4)
|
|
62
|
|
|
165
|
|
|
227
|
|
|
—
|
|
|
5
|
|
|
5
|
|
||||||
Short-term investment funds
|
|
—
|
|
|
15
|
|
|
15
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
|
|
$
|
190
|
|
|
$
|
424
|
|
|
$
|
614
|
|
|
$
|
5
|
|
|
$
|
11
|
|
|
$
|
16
|
|
(1)
|
Substantially all of the assets of these funds are invested in large-cap U.S. companies. The remainder of the assets of these funds is invested in cash reserves.
|
(2)
|
Substantially all of the assets of these funds are invested in small-cap U.S. companies. The remainder of the assets of these funds is invested in cash reserves.
|
(3)
|
Substantially all of the assets of these funds are invested in international companies in developed markets (excluding the U.S.). The remainder of the assets of these funds is invested in cash reserves.
|
(4)
|
This category represents investment grade bonds of U.S. issuers, including U.S. Treasury notes.
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2017
|
|
2016
|
|
2015
|
||||||
|
|
Non-U.S.
Plans
|
|
Non-U.S.
Plans
|
|
Non-U.S.
Plans
|
||||||
Contributions to multi-employer plans
(1)
|
|
$
|
8
|
|
|
$
|
5
|
|
|
$
|
4
|
|
(1)
|
The plan information for both the Pensionskasse der Mitarbeiter der Hoechst-Gruppe VVaG and Pensionskasse der Wacker-Chemie GmbH VVaG plans is publicly available. The plans provide fixed, monthly retirement payments on the basis of the credits earned by the participating employees. To the extent that the plans are underfunded, future contributions to the plans may increase and may be used to fund retirement benefits for employees related to other employers. The Company does not consider either of its multi-employer plans individually significant.
|
|
|
2017
|
|
2016
|
||||||||||||
|
|
U.S. Plans
|
|
Non-U.S.
Plans
|
|
U.S. Plans
|
|
Non-U.S.
Plans
|
||||||||
Change in benefit obligation
|
|
|
|
|
|
|
|
|
||||||||
Benefit obligation, beginning of year
|
|
$
|
80
|
|
|
$
|
3
|
|
|
$
|
18
|
|
|
$
|
—
|
|
Benefit obligation assumed with acquisition
|
|
—
|
|
|
—
|
|
|
69
|
|
|
3
|
|
||||
Service cost
|
|
1
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
Interest cost
|
|
2
|
|
|
—
|
|
|
1
|
|
|
—
|
|
||||
Actuarial loss (gain)
|
|
(1
|
)
|
|
—
|
|
|
(6
|
)
|
|
—
|
|
||||
Benefits paid
|
|
(9
|
)
|
|
—
|
|
|
(2
|
)
|
|
—
|
|
||||
Benefit obligation, end of year
|
|
$
|
73
|
|
|
$
|
3
|
|
|
$
|
80
|
|
|
$
|
3
|
|
|
|
|
|
|
|
|
|
|
||||||||
Change in plan assets
|
|
|
|
|
|
|
|
|
||||||||
Fair value of plan assets, beginning of year
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Employer contribution
|
|
9
|
|
|
—
|
|
|
2
|
|
|
—
|
|
||||
Plan participants' contributions
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
Benefits paid
|
|
(9
|
)
|
|
—
|
|
|
(2
|
)
|
|
—
|
|
||||
Fair value of plan assets, end of year
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Funded status, end of year
|
|
$
|
(73
|
)
|
|
$
|
(3
|
)
|
|
$
|
(80
|
)
|
|
$
|
(3
|
)
|
|
|
2017
|
|
2016
|
||||||||||||
|
|
U.S. Plans
|
|
Non-U.S.
Plans
|
|
U.S. Plans
|
|
Non-U.S.
Plans
|
||||||||
Amounts recognized in the consolidated balance sheet at December 31
|
|
|
|
|
|
|
|
|
||||||||
Current liabilities
|
|
$
|
(8
|
)
|
|
$
|
—
|
|
|
$
|
(8
|
)
|
|
$
|
—
|
|
Noncurrent liabilities
|
|
(65
|
)
|
|
(3
|
)
|
|
(72
|
)
|
|
(3
|
)
|
||||
Net amount recognized
|
|
$
|
(73
|
)
|
|
$
|
(3
|
)
|
|
$
|
(80
|
)
|
|
$
|
(3
|
)
|
|
|
2017
|
|
2016
|
||||||||||||
|
|
U.S. Plans
|
|
Non-U.S.
Plans
|
|
U.S. Plans
|
|
Non-U.S.
Plans
|
||||||||
Amounts recognized in accumulated other comprehensive income (loss)
|
|
|
|
|
|
|
|
|
||||||||
Net loss
|
|
$
|
(5
|
)
|
|
$
|
—
|
|
|
$
|
(4
|
)
|
|
$
|
—
|
|
Total before tax
(1)
|
|
$
|
(5
|
)
|
|
$
|
—
|
|
|
$
|
(4
|
)
|
|
$
|
—
|
|
(1)
|
After-tax totals for post-retirement healthcare benefits were a loss of
$0
and
$1
for
2017
and
2016
, respectively, and are reflected in stockholders' equity as accumulated other comprehensive income (loss).
|
|
|
Year Ended December 31,
|
||||||||||||||||||
|
|
2017
|
|
2016
|
|
2015
|
||||||||||||||
|
|
U.S. Plans
|
|
Non-U.S.
Plans
|
|
U.S. Plans
|
|
Non-U.S.
Plans
|
|
U.S. Plans
|
||||||||||
Components of net periodic benefit cost
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Service cost
|
|
$
|
1
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Interest cost
|
|
2
|
|
|
—
|
|
|
1
|
|
|
—
|
|
|
1
|
|
|||||
Net amortization
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Net periodic benefit cost
|
|
$
|
3
|
|
|
$
|
—
|
|
|
$
|
1
|
|
|
$
|
—
|
|
|
$
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Other changes in plan assets and benefit obligation recognized in OCI
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Net loss (gain) emerging
|
|
$
|
(1
|
)
|
|
$
|
—
|
|
|
$
|
(6
|
)
|
|
$
|
—
|
|
|
$
|
(2
|
)
|
Total recognized in OCI
|
|
$
|
(1
|
)
|
|
$
|
—
|
|
|
$
|
(6
|
)
|
|
$
|
—
|
|
|
$
|
(2
|
)
|
Total net periodic benefit cost and OCI
|
|
$
|
2
|
|
|
$
|
—
|
|
|
$
|
(5
|
)
|
|
$
|
—
|
|
|
$
|
(1
|
)
|
|
|
2017
|
|
2016
|
|
2015
|
|||||||||
|
|
U.S. Plans
|
|
Non-U.S.
Plans
|
|
U.S. Plans
|
|
Non-U.S.
Plans
|
|
U.S. Plans
|
|||||
Weighted average assumptions used to determine benefit obligations at December 31
|
|
|
|
|
|
|
|
|
|
|
|||||
Discount rate
|
|
3.0
|
%
|
|
4.0
|
%
|
|
3.3
|
%
|
|
4.0
|
%
|
|
3.5
|
%
|
Health care cost trend rate
|
|
|
|
|
|
|
|
|
|
|
|||||
- Initial rate
|
|
7.3
|
%
|
|
6.2
|
%
|
|
7.3
|
%
|
|
6.2
|
%
|
|
—
|
%
|
- Ultimate rate
|
|
4.5
|
%
|
|
4.5
|
%
|
|
4.5
|
%
|
|
4.5
|
%
|
|
—
|
%
|
- Years to ultimate
|
|
11
|
|
|
12
|
|
|
11
|
|
|
12
|
|
|
0
|
|
Weighted average assumptions used to determine net periodic benefit costs for years ended December 31
|
|
|
|
|
|
|
|
|
|
|
|||||
Discount rate for benefit obligations
|
|
3.3
|
%
|
|
3.3
|
%
|
|
2.6
|
%
|
|
3.3
|
%
|
|
3.3
|
%
|
Discount rate for service cost
|
|
3.8
|
%
|
|
3.3
|
%
|
|
3.1
|
%
|
|
3.3
|
%
|
|
—
|
%
|
Discount rate for interest cost
|
|
2.6
|
%
|
|
3.3
|
%
|
|
2.8
|
%
|
|
3.3
|
%
|
|
—
|
%
|
Health care cost trend rate
|
|
|
|
|
|
|
|
|
|
|
|||||
- Initial rate
|
|
6.8
|
%
|
|
6.8
|
%
|
|
7.0
|
%
|
|
6.8
|
%
|
|
—
|
%
|
- Ultimate rate
|
|
4.6
|
%
|
|
4.5
|
%
|
|
4.5
|
%
|
|
4.5
|
%
|
|
—
|
%
|
- Years to ultimate
|
|
11
|
|
|
12
|
|
|
12
|
|
|
13
|
|
|
0
|
|
|
|
Pension
Benefits
|
|
Other Post-
retirement
Benefits
|
||||
Estimated future benefit payments:
|
|
|
|
|
||||
Year 1
|
|
$
|
51
|
|
|
$
|
8
|
|
Year 2
|
|
53
|
|
|
8
|
|
||
Year 3
|
|
52
|
|
|
8
|
|
||
Year 4
|
|
52
|
|
|
8
|
|
||
Year 5
|
|
53
|
|
|
8
|
|
||
Years 6 to 10
|
|
265
|
|
|
30
|
|
|
|
Options
|
|
Weighted
Average
Exercise
Price
|
|
Weighted
Average
Remaining
Term
(Years)
|
|
Aggregate
Intrinsic
Value
|
|||||
Outstanding at December 31, 2016
|
|
1,404,734
|
|
|
$
|
33.76
|
|
|
|
|
|
||
Granted
|
|
289,553
|
|
|
61.87
|
|
|
|
|
|
|||
Exercised
|
|
(401,505
|
)
|
|
29.68
|
|
|
|
|
|
|||
Cancelled
|
|
(23,181
|
)
|
|
56.92
|
|
|
|
|
|
|||
Outstanding at December 31, 2017
|
|
1,269,601
|
|
|
$
|
41.04
|
|
|
5.9
|
|
$
|
83
|
|
Exercisable at December 31, 2017
|
|
719,676
|
|
|
$
|
28.89
|
|
|
3.9
|
|
$
|
56
|
|
Range of Prices
|
|
Options
Outstanding
|
|
Weighted
Average
Remaining
Contractual
Life (Years)
|
|
$7.12 - $9.65
|
|
300,366
|
|
|
1.6
|
$10.26 - $18.05
|
|
167,582
|
|
|
3.6
|
$22.92 - $30.05
|
|
316,601
|
|
|
7.6
|
$40.38 - $52.35
|
|
285,553
|
|
|
9.1
|
$61.87 - $68.18
|
|
199,499
|
|
|
6.8
|
|
|
Stock Option Grants
|
||||||||||
|
|
Year Ended December 31,
|
||||||||||
|
|
2017
|
|
2016
|
|
2015
|
||||||
Weighted average fair value
|
|
$
|
15.84
|
|
|
$
|
11.67
|
|
|
$
|
20.21
|
|
Risk-free interest rate
|
|
2.1
|
%
|
|
1.4
|
%
|
|
1.7
|
%
|
|||
Expected life in years
|
|
5
|
|
|
5
|
|
|
5
|
|
|||
Expected volatility
|
|
29.2
|
%
|
|
32.9
|
%
|
|
34.2
|
%
|
|||
Expected dividend yield
|
|
1.2
|
%
|
|
1.6
|
%
|
|
0.9
|
%
|
|
|
Number of
Units
|
|
Weighted
Average
Grant Date
Fair Value
|
|||
Non-vested at December 31, 2016
|
|
597,559
|
|
|
$
|
55.64
|
|
Granted
|
|
198,659
|
|
|
62.46
|
|
|
Vested
|
|
(91,997
|
)
|
|
61.39
|
|
|
Forfeited
|
|
(40,355
|
)
|
|
56.08
|
|
|
Non-vested at December 31, 2017
|
|
663,866
|
|
|
$
|
56.86
|
|
|
|
Liability Classified Restricted Stock Awards
|
|||
|
|
Year Ended December 31, 2017
|
|||
Weighted average vesting period in years
|
|
0.8
|
|
||
Risk-free interest rate
|
|
1.6
|
%
|
||
Expected volatility
|
|
23.1
|
%
|
||
Expected dividend yield
|
|
0.8
|
%
|
|
|
Number of
Units
|
|
Weighted Average Fair Value
|
|||
Non-vested at December 31, 2016
|
|
286,147
|
|
|
$
|
60.77
|
|
Vested
|
|
(161,324
|
)
|
|
65.29
|
|
|
Cancelled
|
|
(23,831
|
)
|
|
66.97
|
|
|
Non-vested at December 31, 2017
|
|
100,992
|
|
|
$
|
106.53
|
|
|
|
2017
|
|
2016
|
||||||||||||
|
|
Carrying
Value
|
|
Fair
Value
|
|
Carrying
Value
|
|
Fair
Value
|
||||||||
Revolving credit facility
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
325
|
|
|
$
|
325
|
|
4.625% Westlake 2021 Senior Notes
(1)
|
|
645
|
|
|
639
|
|
|
652
|
|
|
651
|
|
||||
4.625% Subsidiary 2021 Senior Notes
(1)
|
|
65
|
|
|
65
|
|
|
66
|
|
|
66
|
|
||||
3.60% 2022 Senior Notes
|
|
249
|
|
|
255
|
|
|
248
|
|
|
252
|
|
||||
4.875% Westlake 2023 Senior Notes
|
|
445
|
|
|
449
|
|
|
447
|
|
|
451
|
|
||||
4.875% Subsidiary 2023 Senior Notes
|
|
16
|
|
|
16
|
|
|
17
|
|
|
17
|
|
||||
3.60% 2026 Senior Notes
|
|
740
|
|
|
757
|
|
|
739
|
|
|
722
|
|
||||
Loan related to tax-exempt waste disposal revenue
bonds due 2027
|
|
11
|
|
|
11
|
|
|
11
|
|
|
11
|
|
||||
6 ½% 2029 GO Zone Senior Notes
|
|
99
|
|
|
111
|
|
|
99
|
|
|
112
|
|
||||
6 ¾% 2032 GO Zone Senior Notes
|
|
—
|
|
|
—
|
|
|
248
|
|
|
259
|
|
||||
6 ½% 2035 GO Zone Senior Notes
|
|
88
|
|
|
99
|
|
|
88
|
|
|
100
|
|
||||
6 ½% 2035 IKE Zone Senior Notes
|
|
65
|
|
|
74
|
|
|
65
|
|
|
73
|
|
||||
5.0% 2046 Senior Notes
|
|
675
|
|
|
787
|
|
|
674
|
|
|
692
|
|
||||
4.375% 2047 Senior Notes
|
|
491
|
|
|
518
|
|
|
—
|
|
|
—
|
|
||||
3.50% 2032 Senior Notes
|
|
248
|
|
|
256
|
|
|
—
|
|
|
—
|
|
(1)
|
The
4.625% Westlake 2021 Senior Notes
and
4.625% Subsidiary 2021 Senior Notes
were classified as a component of current liabilities in the consolidated balance sheet at
December 31, 2017
. For additional information, see Note 9.
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2017
|
|
2016
|
|
2015
|
||||||
Domestic
|
|
$
|
917
|
|
|
$
|
476
|
|
|
$
|
880
|
|
Foreign
|
|
164
|
|
|
82
|
|
|
83
|
|
|||
|
|
$
|
1,081
|
|
|
$
|
558
|
|
|
$
|
963
|
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2017
|
|
2016
|
|
2015
|
||||||
Current
|
|
|
|
|
|
|
||||||
Federal
|
|
$
|
231
|
|
|
$
|
8
|
|
|
$
|
225
|
|
State
|
|
18
|
|
|
9
|
|
|
24
|
|
|||
Foreign
|
|
27
|
|
|
20
|
|
|
9
|
|
|||
|
|
276
|
|
|
37
|
|
|
258
|
|
|||
Deferred
|
|
|
|
|
|
|
||||||
Federal
|
|
(557
|
)
|
|
136
|
|
|
30
|
|
|||
State
|
|
25
|
|
|
(33
|
)
|
|
3
|
|
|||
Foreign
|
|
(2
|
)
|
|
(2
|
)
|
|
7
|
|
|||
|
|
(534
|
)
|
|
101
|
|
|
40
|
|
|||
Total provision for (benefit from) income taxes
|
|
$
|
(258
|
)
|
|
$
|
138
|
|
|
$
|
298
|
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2017
|
|
2016
|
|
2015
|
||||||
Provision for federal income tax, at statutory rate
|
|
$
|
378
|
|
|
$
|
195
|
|
|
$
|
337
|
|
State income tax provision, net of federal income tax effect
|
|
26
|
|
|
1
|
|
|
17
|
|
|||
Foreign income tax rate differential
|
|
(33
|
)
|
|
(8
|
)
|
|
(13
|
)
|
|||
Manufacturing deduction
|
|
(23
|
)
|
|
(2
|
)
|
|
(24
|
)
|
|||
Depletion
|
|
(7
|
)
|
|
(2
|
)
|
|
—
|
|
|||
Noncontrolling interests
|
|
(9
|
)
|
|
(7
|
)
|
|
(7
|
)
|
|||
Tax on previously held shares of Axiall Corporation and certain
other acquisition related items
|
|
—
|
|
|
(13
|
)
|
|
—
|
|
|||
Tax Act related adjustment
|
|
(591
|
)
|
|
—
|
|
|
—
|
|
|||
Changes in state apportionment and other state adjustments
|
|
2
|
|
|
(17
|
)
|
|
—
|
|
|||
Research and development expenditures and adjustments related to prior
years' tax returns
|
|
(1
|
)
|
|
(8
|
)
|
|
—
|
|
|||
Other, net
|
|
—
|
|
|
(1
|
)
|
|
(12
|
)
|
|||
|
|
$
|
(258
|
)
|
|
$
|
138
|
|
|
$
|
298
|
|
|
|
2017
|
|
2016
|
||||
Net operating loss carryforward
|
|
$
|
64
|
|
|
$
|
70
|
|
Credit carryforward
|
|
26
|
|
|
24
|
|
||
Accruals
|
|
53
|
|
|
67
|
|
||
Pension
|
|
79
|
|
|
114
|
|
||
Allowance for doubtful accounts
|
|
5
|
|
|
12
|
|
||
Inventories
|
|
11
|
|
|
13
|
|
||
Other
|
|
15
|
|
|
36
|
|
||
Deferred taxes assets—total
|
|
253
|
|
|
336
|
|
||
Property, plant and equipment
|
|
(906
|
)
|
|
(1,374
|
)
|
||
Intangibles
|
|
(154
|
)
|
|
(221
|
)
|
||
Turnaround costs
|
|
(8
|
)
|
|
(1
|
)
|
||
Basis difference—consolidated partnerships
|
|
(209
|
)
|
|
(308
|
)
|
||
Other
|
|
(18
|
)
|
|
(17
|
)
|
||
Deferred tax liabilities—total
|
|
(1,295
|
)
|
|
(1,921
|
)
|
||
Valuation allowance
|
|
(56
|
)
|
|
(53
|
)
|
||
Total net deferred tax liabilities
|
|
$
|
(1,098
|
)
|
|
$
|
(1,638
|
)
|
|
|
|
|
|
||||
Balance sheet classifications
|
|
|
|
|
||||
Noncurrent deferred tax asset
|
|
$
|
13
|
|
|
$
|
12
|
|
Noncurrent deferred tax liability
|
|
(1,111
|
)
|
|
(1,650
|
)
|
||
Total net deferred tax liabilities
|
|
$
|
(1,098
|
)
|
|
$
|
(1,638
|
)
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2017
|
|
2016
|
|
2015
|
||||||
Net income attributable to Westlake Chemical Corporation
|
|
$
|
1,304
|
|
|
$
|
399
|
|
|
$
|
646
|
|
Less:
|
|
|
|
|
|
|
||||||
Net income attributable to participating securities
|
|
(7
|
)
|
|
(2
|
)
|
|
(3
|
)
|
|||
Net income attributable to common shareholders
|
|
$
|
1,297
|
|
|
$
|
397
|
|
|
$
|
643
|
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2017
|
|
2016
|
|
2015
|
||||||
Weighted average common shares—basic
|
|
129,087,043
|
|
|
129,367,712
|
|
|
131,823,707
|
|
|||
Plus incremental shares from:
|
|
|
|
|
|
|
||||||
Assumed exercise of options
|
|
452,970
|
|
|
607,110
|
|
|
478,105
|
|
|||
Weighted average common shares—diluted
|
|
129,540,013
|
|
|
129,974,822
|
|
|
132,301,812
|
|
|||
|
|
|
|
|
|
|
||||||
Earnings per common share attributable to
Westlake Chemical Corporation:
|
|
|
|
|
|
|
||||||
Basic
|
|
$
|
10.05
|
|
|
$
|
3.07
|
|
|
$
|
4.88
|
|
Diluted
|
|
$
|
10.00
|
|
|
$
|
3.06
|
|
|
$
|
4.86
|
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2017
|
|
2016
|
|
2015
|
||||||
Cash paid for:
|
|
|
|
|
|
|
||||||
Interest paid, net of interest capitalized
|
|
$
|
154
|
|
|
$
|
46
|
|
|
$
|
32
|
|
Income taxes paid
|
|
84
|
|
|
3
|
|
|
314
|
|
|
|
Operating
Leases
|
|
Capital
Leases
|
||||
2018
|
|
$
|
108
|
|
|
$
|
3
|
|
2019
|
|
97
|
|
|
3
|
|
||
2020
|
|
73
|
|
|
3
|
|
||
2021
|
|
56
|
|
|
2
|
|
||
2022
|
|
44
|
|
|
2
|
|
||
Thereafter
|
|
651
|
|
|
9
|
|
||
Total minimum lease payments
|
|
$
|
1,029
|
|
|
$
|
22
|
|
Less: Imputed interest costs
|
|
|
|
(12
|
)
|
|||
Present value of net minimum lease payments
|
|
|
|
$
|
10
|
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2017
|
|
2016
|
|
2015
|
||||||
Net external sales
|
|
|
|
|
|
|
||||||
Olefins
|
|
|
|
|
|
|
||||||
Polyethylene
|
|
$
|
1,518
|
|
|
$
|
1,463
|
|
|
$
|
1,651
|
|
Styrene, feedstock and other
|
|
533
|
|
|
431
|
|
|
609
|
|
|||
Total olefins
|
|
2,051
|
|
|
1,894
|
|
|
2,260
|
|
|||
Vinyls
|
|
|
|
|
|
|
||||||
PVC, caustic soda and other
|
|
4,769
|
|
|
2,493
|
|
|
1,718
|
|
|||
Building products
|
|
1,221
|
|
|
689
|
|
|
485
|
|
|||
Total vinyls
|
|
5,990
|
|
|
3,182
|
|
|
2,203
|
|
|||
|
|
$
|
8,041
|
|
|
$
|
5,076
|
|
|
$
|
4,463
|
|
|
|
|
|
|
|
|
||||||
Intersegment sales
|
|
|
|
|
|
|
||||||
Olefins
|
|
$
|
393
|
|
|
$
|
165
|
|
|
$
|
107
|
|
Vinyls
|
|
1
|
|
|
26
|
|
|
1
|
|
|||
|
|
$
|
394
|
|
|
$
|
191
|
|
|
$
|
108
|
|
|
|
|
|
|
|
|
||||||
Income (loss) from operations
|
|
|
|
|
|
|
||||||
Olefins
|
|
$
|
655
|
|
|
$
|
558
|
|
|
$
|
747
|
|
Vinyls
|
|
647
|
|
|
174
|
|
|
255
|
|
|||
Corporate and other
|
|
(69
|
)
|
|
(151
|
)
|
|
(42
|
)
|
|||
|
|
$
|
1,233
|
|
|
$
|
581
|
|
|
$
|
960
|
|
|
|
|
|
|
|
|
||||||
Depreciation and amortization
|
|
|
|
|
|
|
||||||
Olefins
|
|
$
|
145
|
|
|
$
|
136
|
|
|
$
|
111
|
|
Vinyls
|
|
449
|
|
|
238
|
|
|
134
|
|
|||
Corporate and other
|
|
7
|
|
|
4
|
|
|
1
|
|
|||
|
|
$
|
601
|
|
|
$
|
378
|
|
|
$
|
246
|
|
|
|
|
|
|
|
|
||||||
Other income (expense), net
|
|
|
|
|
|
|
||||||
Olefins
|
|
$
|
3
|
|
|
$
|
5
|
|
|
$
|
5
|
|
Vinyls
|
|
(1
|
)
|
|
3
|
|
|
8
|
|
|||
Corporate and other
|
|
5
|
|
|
48
|
|
|
25
|
|
|||
|
|
$
|
7
|
|
|
$
|
56
|
|
|
$
|
38
|
|
|
|
|
|
|
|
|
||||||
Provision for (benefit from) income taxes
|
|
|
|
|
|
|
||||||
Olefins
|
|
$
|
63
|
|
|
$
|
175
|
|
|
$
|
243
|
|
Vinyls
|
|
(302
|
)
|
|
25
|
|
|
64
|
|
|||
Corporate and other
|
|
(19
|
)
|
|
(62
|
)
|
|
(9
|
)
|
|||
|
|
$
|
(258
|
)
|
|
$
|
138
|
|
|
$
|
298
|
|
|
|
|
|
|
|
|
||||||
Capital expenditures
|
|
|
|
|
|
|
||||||
Olefins
|
|
$
|
97
|
|
|
$
|
324
|
|
|
$
|
305
|
|
Vinyls
|
|
459
|
|
|
302
|
|
|
176
|
|
|||
Corporate and other
|
|
21
|
|
|
3
|
|
|
10
|
|
|||
|
|
$
|
577
|
|
|
$
|
629
|
|
|
$
|
491
|
|
|
|
December 31, 2017
|
|
December 31, 2016
|
||||
Total assets
|
|
|
|
|
||||
Olefins
|
|
$
|
2,006
|
|
|
$
|
2,093
|
|
Vinyls
|
|
8,853
|
|
|
8,287
|
|
||
Corporate and other
|
|
1,217
|
|
|
510
|
|
||
|
|
$
|
12,076
|
|
|
$
|
10,890
|
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2017
|
|
2016
|
|
2015
|
||||||
Income from operations for reportable segments
|
|
$
|
1,233
|
|
|
$
|
581
|
|
|
$
|
960
|
|
Interest expense
|
|
(159
|
)
|
|
(79
|
)
|
|
(35
|
)
|
|||
Other income, net
|
|
7
|
|
|
56
|
|
|
38
|
|
|||
Income before income taxes
|
|
$
|
1,081
|
|
|
$
|
558
|
|
|
$
|
963
|
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2017
|
|
2016
|
|
2015
|
||||||
Sales to external customers
(1)
|
|
|
|
|
|
|
||||||
United States
|
|
$
|
5,739
|
|
|
$
|
3,526
|
|
|
$
|
3,133
|
|
Foreign
|
|
|
|
|
|
|
||||||
Canada
|
|
653
|
|
|
317
|
|
|
196
|
|
|||
Germany
|
|
432
|
|
|
402
|
|
|
394
|
|
|||
Switzerland
|
|
142
|
|
|
101
|
|
|
107
|
|
|||
Brazil
|
|
108
|
|
|
41
|
|
|
16
|
|
|||
China
|
|
104
|
|
|
87
|
|
|
46
|
|
|||
Italy
|
|
96
|
|
|
84
|
|
|
90
|
|
|||
Taiwan
|
|
96
|
|
|
25
|
|
|
—
|
|
|||
Other
|
|
671
|
|
|
493
|
|
|
481
|
|
|||
|
|
$
|
8,041
|
|
|
$
|
5,076
|
|
|
$
|
4,463
|
|
|
|
December 31, 2017
|
|
December 31, 2016
|
||||
Long-lived assets
|
|
|
|
|
||||
United States
|
|
$
|
5,668
|
|
|
$
|
5,783
|
|
Foreign
|
|
|
|
|
||||
Germany
|
|
504
|
|
|
401
|
|
||
Other
|
|
240
|
|
|
236
|
|
||
|
|
$
|
6,412
|
|
|
$
|
6,420
|
|
(1)
|
Revenues are attributed to countries based on location of customer.
|
|
|
Westlake
Chemical
Corporation
|
|
100% Owned
Guarantor
Subsidiaries
|
|
Non-Guarantor
Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||
Balance Sheet
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Current assets
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Cash and cash equivalents
|
|
$
|
1,089
|
|
|
$
|
57
|
|
|
$
|
385
|
|
|
$
|
—
|
|
|
$
|
1,531
|
|
Accounts receivable, net
|
|
3,331
|
|
|
4,128
|
|
|
580
|
|
|
(7,038
|
)
|
|
1,001
|
|
|||||
Inventories
|
|
—
|
|
|
654
|
|
|
246
|
|
|
—
|
|
|
900
|
|
|||||
Prepaid expenses and other current assets
|
|
52
|
|
|
26
|
|
|
31
|
|
|
(79
|
)
|
|
30
|
|
|||||
Restricted cash
|
|
—
|
|
|
1
|
|
|
—
|
|
|
—
|
|
|
1
|
|
|||||
Total current assets
|
|
4,472
|
|
|
4,866
|
|
|
1,242
|
|
|
(7,117
|
)
|
|
3,463
|
|
|||||
Property, plant and equipment, net
|
|
—
|
|
|
4,374
|
|
|
2,038
|
|
|
—
|
|
|
6,412
|
|
|||||
Goodwill
|
|
—
|
|
|
855
|
|
|
157
|
|
|
—
|
|
|
1,012
|
|
|||||
Customer relationships, net
|
|
—
|
|
|
479
|
|
|
137
|
|
|
—
|
|
|
616
|
|
|||||
Other intangible assets, net
|
|
—
|
|
|
88
|
|
|
73
|
|
|
—
|
|
|
161
|
|
|||||
Other assets, net
|
|
10,706
|
|
|
798
|
|
|
1,271
|
|
|
(12,363
|
)
|
|
412
|
|
|||||
Total assets
|
|
$
|
15,178
|
|
|
$
|
11,460
|
|
|
$
|
4,918
|
|
|
$
|
(19,480
|
)
|
|
$
|
12,076
|
|
Current liabilities
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Accounts payable
|
|
$
|
6,367
|
|
|
$
|
864
|
|
|
$
|
224
|
|
|
$
|
(6,855
|
)
|
|
$
|
600
|
|
Accrued liabilities
|
|
189
|
|
|
484
|
|
|
246
|
|
|
(262
|
)
|
|
657
|
|
|||||
Current portion of long-term debt, net
|
|
710
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
710
|
|
|||||
Total current liabilities
|
|
7,266
|
|
|
1,348
|
|
|
470
|
|
|
(7,117
|
)
|
|
1,967
|
|
|||||
Long-term debt, net
|
|
3,034
|
|
|
4,242
|
|
|
220
|
|
|
(4,369
|
)
|
|
3,127
|
|
|||||
Deferred income taxes
|
|
—
|
|
|
1,026
|
|
|
92
|
|
|
(7
|
)
|
|
1,111
|
|
|||||
Pension and other liabilities
|
|
4
|
|
|
347
|
|
|
151
|
|
|
—
|
|
|
502
|
|
|||||
Total liabilities
|
|
10,304
|
|
|
6,963
|
|
|
933
|
|
|
(11,493
|
)
|
|
6,707
|
|
|||||
Total Westlake Chemical Corporation stockholders' equity
|
|
4,874
|
|
|
4,497
|
|
|
3,490
|
|
|
(7,987
|
)
|
|
4,874
|
|
|||||
Noncontrolling interests
|
|
—
|
|
|
—
|
|
|
495
|
|
|
—
|
|
|
495
|
|
|||||
Total equity
|
|
4,874
|
|
|
4,497
|
|
|
3,985
|
|
|
(7,987
|
)
|
|
5,369
|
|
|||||
Total liabilities and equity
|
|
$
|
15,178
|
|
|
$
|
11,460
|
|
|
$
|
4,918
|
|
|
$
|
(19,480
|
)
|
|
$
|
12,076
|
|
|
|
Westlake
Chemical
Corporation
|
|
100% Owned
Guarantor
Subsidiaries
|
|
Non-Guarantor
Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||
Balance Sheet
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Current assets
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Cash and cash equivalents
|
|
$
|
147
|
|
|
$
|
53
|
|
|
$
|
259
|
|
|
$
|
—
|
|
|
$
|
459
|
|
Accounts receivable, net
|
|
2,118
|
|
|
3,330
|
|
|
324
|
|
|
(4,833
|
)
|
|
939
|
|
|||||
Inventories
|
|
—
|
|
|
598
|
|
|
203
|
|
|
—
|
|
|
801
|
|
|||||
Prepaid expenses and other current assets
|
|
31
|
|
|
42
|
|
|
12
|
|
|
(37
|
)
|
|
48
|
|
|||||
Restricted cash
|
|
—
|
|
|
—
|
|
|
161
|
|
|
—
|
|
|
161
|
|
|||||
Total current assets
|
|
2,296
|
|
|
4,023
|
|
|
959
|
|
|
(4,870
|
)
|
|
2,408
|
|
|||||
Property, plant and equipment, net
|
|
—
|
|
|
4,476
|
|
|
1,944
|
|
|
—
|
|
|
6,420
|
|
|||||
Goodwill
|
|
—
|
|
|
792
|
|
|
155
|
|
|
—
|
|
|
947
|
|
|||||
Customer relationships, net
|
|
—
|
|
|
468
|
|
|
143
|
|
|
—
|
|
|
611
|
|
|||||
Other intangible assets, net
|
|
—
|
|
|
131
|
|
|
70
|
|
|
(25
|
)
|
|
176
|
|
|||||
Other assets, net
|
|
9,170
|
|
|
874
|
|
|
1,116
|
|
|
(10,832
|
)
|
|
328
|
|
|||||
Total assets
|
|
$
|
11,466
|
|
|
$
|
10,764
|
|
|
$
|
4,387
|
|
|
$
|
(15,727
|
)
|
|
$
|
10,890
|
|
Current liabilities
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Accounts payable
|
|
$
|
4,331
|
|
|
$
|
748
|
|
|
$
|
225
|
|
|
$
|
(4,808
|
)
|
|
$
|
496
|
|
Accrued liabilities
|
|
26
|
|
|
390
|
|
|
183
|
|
|
(61
|
)
|
|
538
|
|
|||||
Term loan
|
|
—
|
|
|
—
|
|
|
149
|
|
|
—
|
|
|
149
|
|
|||||
Total current liabilities
|
|
4,357
|
|
|
1,138
|
|
|
557
|
|
|
(4,869
|
)
|
|
1,183
|
|
|||||
Long-term debt, net
|
|
3,585
|
|
|
4,091
|
|
|
—
|
|
|
(3,997
|
)
|
|
3,679
|
|
|||||
Deferred income taxes
|
|
—
|
|
|
1,581
|
|
|
92
|
|
|
(23
|
)
|
|
1,650
|
|
|||||
Pension and other liabilities
|
|
—
|
|
|
361
|
|
|
125
|
|
|
—
|
|
|
486
|
|
|||||
Total liabilities
|
|
7,942
|
|
|
7,171
|
|
|
774
|
|
|
(8,889
|
)
|
|
6,998
|
|
|||||
Total Westlake Chemical Corporation stockholders' equity
|
|
3,524
|
|
|
3,593
|
|
|
3,245
|
|
|
(6,838
|
)
|
|
3,524
|
|
|||||
Noncontrolling interests
|
|
—
|
|
|
—
|
|
|
368
|
|
|
—
|
|
|
368
|
|
|||||
Total equity
|
|
3,524
|
|
|
3,593
|
|
|
3,613
|
|
|
(6,838
|
)
|
|
3,892
|
|
|||||
Total liabilities and equity
|
|
$
|
11,466
|
|
|
$
|
10,764
|
|
|
$
|
4,387
|
|
|
$
|
(15,727
|
)
|
|
$
|
10,890
|
|
|
|
Westlake
Chemical
Corporation
|
|
100% Owned
Guarantor
Subsidiaries
|
|
Non-Guarantor
Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||
Statement of Operations
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Net sales
|
|
$
|
—
|
|
|
$
|
6,650
|
|
|
$
|
3,143
|
|
|
$
|
(1,752
|
)
|
|
$
|
8,041
|
|
Cost of sales
|
|
—
|
|
|
5,559
|
|
|
2,438
|
|
|
(1,725
|
)
|
|
6,272
|
|
|||||
Gross profit
|
|
—
|
|
|
1,091
|
|
|
705
|
|
|
(27
|
)
|
|
1,769
|
|
|||||
Selling, general and administrative expenses
|
|
3
|
|
|
292
|
|
|
131
|
|
|
(27
|
)
|
|
399
|
|
|||||
Amortization of intangibles
|
|
1
|
|
|
81
|
|
|
26
|
|
|
—
|
|
|
108
|
|
|||||
Transaction and integration-related costs
|
|
—
|
|
|
27
|
|
|
2
|
|
|
—
|
|
|
29
|
|
|||||
Income (loss) from operations
|
|
(4
|
)
|
|
691
|
|
|
546
|
|
|
—
|
|
|
1,233
|
|
|||||
Other income (expense)
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Interest expense
|
|
(154
|
)
|
|
(178
|
)
|
|
(6
|
)
|
|
179
|
|
|
(159
|
)
|
|||||
Other income (expense), net
|
|
154
|
|
|
(3
|
)
|
|
35
|
|
|
(179
|
)
|
|
7
|
|
|||||
Income (loss) before income taxes
|
|
(4
|
)
|
|
510
|
|
|
575
|
|
|
—
|
|
|
1,081
|
|
|||||
Provision for (benefit from) income taxes
|
|
10
|
|
|
(312
|
)
|
|
44
|
|
|
—
|
|
|
(258
|
)
|
|||||
Equity in net income of subsidiaries
|
|
1,318
|
|
|
—
|
|
|
—
|
|
|
(1,318
|
)
|
|
—
|
|
|||||
Net income (loss)
|
|
1,304
|
|
|
822
|
|
|
531
|
|
|
(1,318
|
)
|
|
1,339
|
|
|||||
Net income attributable to noncontrolling interests
|
|
—
|
|
|
—
|
|
|
35
|
|
|
—
|
|
|
35
|
|
|||||
Net income (loss) attributable to Westlake Chemical Corporation
|
|
$
|
1,304
|
|
|
$
|
822
|
|
|
$
|
496
|
|
|
$
|
(1,318
|
)
|
|
$
|
1,304
|
|
Comprehensive income attributable to Westlake Chemical Corporation
|
|
$
|
1,432
|
|
|
$
|
833
|
|
|
$
|
493
|
|
|
$
|
(1,326
|
)
|
|
$
|
1,432
|
|
|
|
Westlake
Chemical
Corporation
|
|
100% Owned
Guarantor
Subsidiaries
|
|
Non-Guarantor
Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||
Statement of Operations
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Net sales
|
|
$
|
—
|
|
|
$
|
4,010
|
|
|
$
|
2,445
|
|
|
$
|
(1,379
|
)
|
|
$
|
5,076
|
|
Cost of sales
|
|
—
|
|
|
3,533
|
|
|
1,919
|
|
|
(1,357
|
)
|
|
4,095
|
|
|||||
Gross profit
|
|
—
|
|
|
477
|
|
|
526
|
|
|
(22
|
)
|
|
981
|
|
|||||
Selling, general and administrative expenses
|
|
2
|
|
|
178
|
|
|
100
|
|
|
(22
|
)
|
|
258
|
|
|||||
Amortization of intangibles
|
|
1
|
|
|
27
|
|
|
10
|
|
|
—
|
|
|
38
|
|
|||||
Transaction and integration-related costs
|
|
—
|
|
|
103
|
|
|
1
|
|
|
—
|
|
|
104
|
|
|||||
Income (loss) from operations
|
|
(3
|
)
|
|
169
|
|
|
415
|
|
|
—
|
|
|
581
|
|
|||||
Other income (expense)
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Interest expense
|
|
(83
|
)
|
|
(76
|
)
|
|
(2
|
)
|
|
82
|
|
|
(79
|
)
|
|||||
Other income (expense), net
|
|
77
|
|
|
(14
|
)
|
|
75
|
|
|
(82
|
)
|
|
56
|
|
|||||
Income (loss) before income taxes
|
|
(9
|
)
|
|
79
|
|
|
488
|
|
|
—
|
|
|
558
|
|
|||||
Provision for (benefit from) income taxes
|
|
(8
|
)
|
|
115
|
|
|
31
|
|
|
—
|
|
|
138
|
|
|||||
Equity in net income of subsidiaries
|
|
400
|
|
|
—
|
|
|
—
|
|
|
(400
|
)
|
|
—
|
|
|||||
Net income (loss)
|
|
399
|
|
|
(36
|
)
|
|
457
|
|
|
(400
|
)
|
|
420
|
|
|||||
Net income attributable to noncontrolling interests
|
|
—
|
|
|
—
|
|
|
21
|
|
|
—
|
|
|
21
|
|
|||||
Net income (loss) attributable to Westlake Chemical Corporation
|
|
$
|
399
|
|
|
$
|
(36
|
)
|
|
$
|
436
|
|
|
$
|
(400
|
)
|
|
$
|
399
|
|
Comprehensive income attributable to Westlake Chemical Corporation
|
|
$
|
407
|
|
|
$
|
11
|
|
|
$
|
396
|
|
|
$
|
(407
|
)
|
|
$
|
407
|
|
|
|
Westlake
Chemical
Corporation
|
|
100% Owned
Guarantor
Subsidiaries
|
|
Non-Guarantor
Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||
Statement of Operations
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Net sales
|
|
$
|
—
|
|
|
$
|
3,558
|
|
|
$
|
2,286
|
|
|
$
|
(1,381
|
)
|
|
$
|
4,463
|
|
Cost of sales
|
|
—
|
|
|
2,842
|
|
|
1,797
|
|
|
(1,361
|
)
|
|
3,278
|
|
|||||
Gross profit
|
|
—
|
|
|
716
|
|
|
489
|
|
|
(20
|
)
|
|
1,185
|
|
|||||
Selling, general and administrative expenses
|
|
3
|
|
|
146
|
|
|
89
|
|
|
(20
|
)
|
|
218
|
|
|||||
Amortization of intangibles
|
|
—
|
|
|
5
|
|
|
2
|
|
|
—
|
|
|
7
|
|
|||||
Income (loss) from operations
|
|
(3
|
)
|
|
565
|
|
|
398
|
|
|
—
|
|
|
960
|
|
|||||
Other income (expense)
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Interest expense
|
|
(42
|
)
|
|
(35
|
)
|
|
—
|
|
|
42
|
|
|
(35
|
)
|
|||||
Other income (expense), net
|
|
20
|
|
|
5
|
|
|
55
|
|
|
(42
|
)
|
|
38
|
|
|||||
Income (loss) before income taxes
|
|
(25
|
)
|
|
535
|
|
|
453
|
|
|
—
|
|
|
963
|
|
|||||
Provision for (benefit from) income taxes
|
|
(7
|
)
|
|
275
|
|
|
30
|
|
|
—
|
|
|
298
|
|
|||||
Equity in net income of subsidiaries
|
|
664
|
|
|
—
|
|
|
—
|
|
|
(664
|
)
|
|
—
|
|
|||||
Net income (loss)
|
|
646
|
|
|
260
|
|
|
423
|
|
|
(664
|
)
|
|
665
|
|
|||||
Net income attributable to noncontrolling interests
|
|
—
|
|
|
—
|
|
|
19
|
|
|
—
|
|
|
19
|
|
|||||
Net income (loss) attributable to Westlake Chemical Corporation
|
|
$
|
646
|
|
|
$
|
260
|
|
|
$
|
404
|
|
|
$
|
(664
|
)
|
|
$
|
646
|
|
Comprehensive income attributable to Westlake Chemical Corporation
|
|
$
|
596
|
|
|
$
|
261
|
|
|
$
|
335
|
|
|
$
|
(596
|
)
|
|
$
|
596
|
|
|
|
Westlake
Chemical
Corporation
|
|
100% Owned
Guarantor
Subsidiaries
|
|
Non-Guarantor
Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||
Statement of Cash Flows
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Cash flows from operating activities
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Net income (loss)
|
|
$
|
1,304
|
|
|
$
|
822
|
|
|
$
|
531
|
|
|
$
|
(1,318
|
)
|
|
$
|
1,339
|
|
Adjustments to reconcile net income to net cash provided by (used for) operating
activities
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Depreciation and amortization
|
|
—
|
|
|
395
|
|
|
206
|
|
|
—
|
|
|
601
|
|
|||||
Deferred income taxes
|
|
12
|
|
|
(535
|
)
|
|
(11
|
)
|
|
—
|
|
|
(534
|
)
|
|||||
Net changes in working capital and other
|
|
(1,327
|
)
|
|
41
|
|
|
100
|
|
|
1,318
|
|
|
132
|
|
|||||
Net cash provided by (used for) operating activities
|
|
(11
|
)
|
|
723
|
|
|
826
|
|
|
—
|
|
|
1,538
|
|
|||||
Cash flows from investing activities
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Acquisition of business, net of cash acquired
|
|
—
|
|
|
(13
|
)
|
|
—
|
|
|
—
|
|
|
(13
|
)
|
|||||
Additions to property, plant and equipment
|
|
—
|
|
|
(407
|
)
|
|
(170
|
)
|
|
—
|
|
|
(577
|
)
|
|||||
Additions to cost method investment
|
|
—
|
|
|
(66
|
)
|
|
—
|
|
|
—
|
|
|
(66
|
)
|
|||||
Other
|
|
—
|
|
|
2
|
|
|
(134
|
)
|
|
136
|
|
|
4
|
|
|||||
Net cash provided by (used for) investing activities
|
|
—
|
|
|
(484
|
)
|
|
(304
|
)
|
|
136
|
|
|
(652
|
)
|
|||||
Cash flows from financing activities
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Intercompany financing
|
|
746
|
|
|
(611
|
)
|
|
(135
|
)
|
|
—
|
|
|
—
|
|
|||||
Receivable under the investment management agreement
|
|
136
|
|
|
—
|
|
|
—
|
|
|
(136
|
)
|
|
—
|
|
|||||
Debt issuance costs
|
|
(6
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(6
|
)
|
|||||
Dividends paid
|
|
(103
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(103
|
)
|
|||||
Distributions to noncontrolling interests
|
|
—
|
|
|
376
|
|
|
(404
|
)
|
|
—
|
|
|
(28
|
)
|
|||||
Proceeds from debt issuance and drawdown of revolver
|
|
225
|
|
|
—
|
|
|
8
|
|
|
—
|
|
|
233
|
|
|||||
Net proceeds from issuance of Westlake Chemical Partners LP common units
|
|
—
|
|
|
—
|
|
|
111
|
|
|
—
|
|
|
111
|
|
|||||
Proceeds from senior notes issuance
|
|
745
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
745
|
|
|||||
Repayment of term loan
|
|
—
|
|
|
—
|
|
|
(150
|
)
|
|
—
|
|
|
(150
|
)
|
|||||
Restricted cash associated with term loan
|
|
—
|
|
|
—
|
|
|
154
|
|
|
—
|
|
|
154
|
|
|||||
Repayment of revolver
|
|
(550
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(550
|
)
|
|||||
Repayment of notes payable
|
|
(251
|
)
|
|
—
|
|
|
(6
|
)
|
|
—
|
|
|
(257
|
)
|
|||||
Other
|
|
11
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
11
|
|
|||||
Net cash provided by (used for) financing activities
|
|
953
|
|
|
(235
|
)
|
|
(422
|
)
|
|
(136
|
)
|
|
160
|
|
|
|
Westlake
Chemical
Corporation
|
|
100% Owned
Guarantor
Subsidiaries
|
|
Non-Guarantor
Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||
Effect of exchange rate changes on cash and cash equivalents
|
|
—
|
|
|
—
|
|
|
26
|
|
|
—
|
|
|
26
|
|
|||||
Net increase (decrease) in cash and cash equivalents
|
|
942
|
|
|
4
|
|
|
126
|
|
|
—
|
|
|
1,072
|
|
|||||
Cash and cash equivalents at beginning of the year
|
|
147
|
|
|
53
|
|
|
259
|
|
|
—
|
|
|
459
|
|
|||||
Cash and cash equivalents at end of the year
|
|
$
|
1,089
|
|
|
$
|
57
|
|
|
$
|
385
|
|
|
$
|
—
|
|
|
$
|
1,531
|
|
|
|
Westlake
Chemical
Corporation
|
|
100% Owned
Guarantor
Subsidiaries
|
|
Non-Guarantor
Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||
Statement of Cash Flows
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Cash flows from operating activities
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Net income (loss)
|
|
$
|
399
|
|
|
$
|
(36
|
)
|
|
$
|
457
|
|
|
$
|
(400
|
)
|
|
$
|
420
|
|
Adjustments to reconcile net income to net cash provided by (used for) operating
activities
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Depreciation and amortization
|
|
—
|
|
|
217
|
|
|
161
|
|
|
—
|
|
|
378
|
|
|||||
Deferred income taxes
|
|
1
|
|
|
103
|
|
|
(3
|
)
|
|
—
|
|
|
101
|
|
|||||
Net changes in working capital and other
|
|
(437
|
)
|
|
90
|
|
|
(118
|
)
|
|
400
|
|
|
(65
|
)
|
|||||
Net cash provided by (used for) operating activities
|
|
(37
|
)
|
|
374
|
|
|
497
|
|
|
—
|
|
|
834
|
|
|||||
Cash flows from investing activities
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Acquisition of business, net of cash acquired
|
|
—
|
|
|
(2,502
|
)
|
|
64
|
|
|
—
|
|
|
(2,438
|
)
|
|||||
Additions to property, plant and equipment
|
|
—
|
|
|
(275
|
)
|
|
(354
|
)
|
|
—
|
|
|
(629
|
)
|
|||||
Additions to cost method investments
|
|
—
|
|
|
(17
|
)
|
|
—
|
|
|
—
|
|
|
(17
|
)
|
|||||
Proceeds from sales and maturities of securities
|
|
658
|
|
|
—
|
|
|
5
|
|
|
—
|
|
|
663
|
|
|||||
Purchase of securities
|
|
(138
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(138
|
)
|
|||||
Other
|
|
—
|
|
|
(4
|
)
|
|
—
|
|
|
—
|
|
|
(4
|
)
|
|||||
Net cash provided by (used for) investing activities
|
|
520
|
|
|
(2,798
|
)
|
|
(285
|
)
|
|
—
|
|
|
(2,563
|
)
|
|||||
Cash flows from financing activities
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Intercompany financing
|
|
(2,199
|
)
|
|
2,207
|
|
|
(8
|
)
|
|
—
|
|
|
—
|
|
|||||
Debt issuance costs
|
|
(35
|
)
|
|
—
|
|
|
(1
|
)
|
|
—
|
|
|
(36
|
)
|
|||||
Dividends paid
|
|
(97
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(97
|
)
|
|||||
Distributions paid
|
|
—
|
|
|
263
|
|
|
(280
|
)
|
|
—
|
|
|
(17
|
)
|
|||||
Proceeds from debt issuance and drawdown of revolver
|
|
450
|
|
|
—
|
|
|
158
|
|
|
—
|
|
|
608
|
|
|||||
Proceeds from senior notes issuance
|
|
1,429
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1,429
|
|
|||||
Restricted cash associated with term loan
|
|
—
|
|
|
—
|
|
|
(154
|
)
|
|
—
|
|
|
(154
|
)
|
|||||
Repayment of revolver
|
|
(125
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(125
|
)
|
|||||
Repayment of notes payable
|
|
—
|
|
|
—
|
|
|
(13
|
)
|
|
—
|
|
|
(13
|
)
|
|||||
Repurchase of common stock for treasury
|
|
(67
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(67
|
)
|
|||||
Other
|
|
5
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
5
|
|
|||||
Net cash provided by (used for) financing activities
|
|
(639
|
)
|
|
2,470
|
|
|
(298
|
)
|
|
—
|
|
|
1,533
|
|
|
|
Westlake
Chemical
Corporation
|
|
100% Owned
Guarantor
Subsidiaries
|
|
Non-Guarantor
Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||
Effect of exchange rate changes on cash and cash equivalents
|
|
—
|
|
|
—
|
|
|
(8
|
)
|
|
—
|
|
|
(8
|
)
|
|||||
Net increase (decrease) in cash and cash equivalents
|
|
(156
|
)
|
|
46
|
|
|
(94
|
)
|
|
—
|
|
|
(204
|
)
|
|||||
Cash and cash equivalents at beginning of the year
|
|
303
|
|
|
7
|
|
|
353
|
|
|
—
|
|
|
663
|
|
|||||
Cash and cash equivalents at end of the year
|
|
$
|
147
|
|
|
$
|
53
|
|
|
$
|
259
|
|
|
$
|
—
|
|
|
$
|
459
|
|
|
|
Westlake
Chemical
Corporation
|
|
100% Owned
Guarantor
Subsidiaries
|
|
Non-Guarantor
Subsidiaries
|
|
Eliminations
|
|
Consolidated
|
||||||||||
Statement of Cash Flows
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Cash flows from operating activities
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Net income (loss)
|
|
$
|
646
|
|
|
$
|
260
|
|
|
$
|
423
|
|
|
$
|
(664
|
)
|
|
$
|
665
|
|
Adjustments to reconcile net income to net cash provided by (used for) operating
activities
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Depreciation and amortization
|
|
—
|
|
|
114
|
|
|
132
|
|
|
—
|
|
|
246
|
|
|||||
Deferred income taxes
|
|
—
|
|
|
39
|
|
|
1
|
|
|
—
|
|
|
40
|
|
|||||
Net changes in working capital and other
|
|
(659
|
)
|
|
93
|
|
|
30
|
|
|
664
|
|
|
128
|
|
|||||
Net cash provided by (used for) operating activities
|
|
(13
|
)
|
|
506
|
|
|
586
|
|
|
—
|
|
|
1,079
|
|
|||||
Cash flows from investing activities
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Acquisition of business, net of cash acquired
|
|
—
|
|
|
—
|
|
|
16
|
|
|
—
|
|
|
16
|
|
|||||
Additions to property, plant and equipment
|
|
—
|
|
|
(215
|
)
|
|
(276
|
)
|
|
—
|
|
|
(491
|
)
|
|||||
Proceeds from disposition of equity method investments
|
|
—
|
|
|
28
|
|
|
—
|
|
|
—
|
|
|
28
|
|
|||||
Proceeds from sales and maturities of securities
|
|
49
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
49
|
|
|||||
Purchase of securities
|
|
(556
|
)
|
|
(49
|
)
|
|
—
|
|
|
—
|
|
|
(605
|
)
|
|||||
Other
|
|
—
|
|
|
(3
|
)
|
|
—
|
|
|
—
|
|
|
(3
|
)
|
|||||
Net cash used for investing activities
|
|
(507
|
)
|
|
(239
|
)
|
|
(260
|
)
|
|
—
|
|
|
(1,006
|
)
|
|||||
Cash flows from financing activities
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Intercompany financing
|
|
418
|
|
|
(590
|
)
|
|
172
|
|
|
—
|
|
|
—
|
|
|||||
Dividends paid
|
|
(92
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(92
|
)
|
|||||
Distributions paid
|
|
—
|
|
|
327
|
|
|
(342
|
)
|
|
—
|
|
|
(15
|
)
|
|||||
Proceeds from debt issuance
|
|
—
|
|
|
—
|
|
|
53
|
|
|
—
|
|
|
53
|
|
|||||
Repayment of notes payable
|
|
—
|
|
|
—
|
|
|
(74
|
)
|
|
—
|
|
|
(74
|
)
|
|||||
Repurchase of common stock for treasury
|
|
(163
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(163
|
)
|
|||||
Other
|
|
4
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
4
|
|
|||||
Net cash provided by (used for) financing activities
|
|
167
|
|
|
(263
|
)
|
|
(191
|
)
|
|
—
|
|
|
(287
|
)
|
|||||
Effect of exchange rate changes on cash and cash equivalents
|
|
—
|
|
|
—
|
|
|
(4
|
)
|
|
—
|
|
|
(4
|
)
|
|||||
Net increase (decrease) in cash and cash equivalents
|
|
(353
|
)
|
|
4
|
|
|
131
|
|
|
—
|
|
|
(218
|
)
|
|||||
Cash and cash equivalents at beginning of the year
|
|
656
|
|
|
3
|
|
|
222
|
|
|
—
|
|
|
881
|
|
|||||
Cash and cash equivalents at end of the year
|
|
$
|
303
|
|
|
$
|
7
|
|
|
$
|
353
|
|
|
$
|
—
|
|
|
$
|
663
|
|
|
|
Three Months Ended
|
||||||||||||||
|
|
March 31,
2017 |
|
June 30,
2017 |
|
September 30,
2017 |
|
December 31,
2017 |
||||||||
Net sales
|
|
$
|
1,943
|
|
|
$
|
1,979
|
|
|
$
|
2,109
|
|
|
$
|
2,010
|
|
Gross profit
|
|
368
|
|
|
405
|
|
|
498
|
|
|
498
|
|
||||
Income from operations
|
|
236
|
|
|
266
|
|
|
366
|
|
|
365
|
|
||||
Net income
|
|
145
|
|
|
159
|
|
|
219
|
|
|
816
|
|
||||
Net income attributable to
Westlake Chemical Corporation
|
|
138
|
|
|
153
|
|
|
211
|
|
|
802
|
|
||||
Earnings per common share attributable to
Westlake Chemical Corporation: (1) |
|
|
|
|
|
|
|
|
||||||||
Basic
|
|
$
|
1.07
|
|
|
$
|
1.18
|
|
|
$
|
1.62
|
|
|
$
|
6.18
|
|
Diluted
|
|
$
|
1.06
|
|
|
$
|
1.17
|
|
|
$
|
1.61
|
|
|
$
|
6.15
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
Three Months Ended
|
||||||||||||||
|
|
March 31,
2016 |
|
June 30,
2016 |
|
September 30,
2016 |
|
December 31,
2016 |
||||||||
Net sales
|
|
$
|
975
|
|
|
$
|
1,086
|
|
|
$
|
1,280
|
|
|
$
|
1,735
|
|
Gross profit
|
|
255
|
|
|
241
|
|
|
203
|
|
|
282
|
|
||||
Income from operations
|
|
202
|
|
|
180
|
|
|
46
|
|
|
153
|
|
||||
Net income
|
|
129
|
|
|
116
|
|
|
70
|
|
|
105
|
|
||||
Net income attributable to
Westlake Chemical Corporation
|
|
123
|
|
|
111
|
|
|
66
|
|
|
99
|
|
||||
Earnings per common share attributable to
Westlake Chemical Corporation: (1) |
|
|
|
|
|
|
|
|
||||||||
Basic
|
|
$
|
0.94
|
|
|
$
|
0.85
|
|
|
$
|
0.51
|
|
|
$
|
0.76
|
|
Diluted
|
|
$
|
0.94
|
|
|
$
|
0.85
|
|
|
$
|
0.51
|
|
|
$
|
0.76
|
|
(1)
|
Basic and diluted earnings per common share ("EPS") for each quarter is computed using the weighted average shares outstanding during that quarter, while EPS for the year is computed using the weighted average shares outstanding for the year. As a result, the sum of the EPS for each of the four quarters may not equal the EPS for the year.
|
(a)(1)
|
The financial statements listed in the Index to Consolidated Financial Statements in Item 8 of this Form 10-K are filed as part of this Form 10-K.
|
|
|
(a)(2)
|
All schedules are omitted because the information is not applicable, not required, or has been furnished in the Consolidated Financial Statements or Notes thereto in Item 8 of this Form 10-K.
|
(a)(3)
|
Exhibits
|
Exhibit No.
|
|
Exhibit Index
|
|
|
|
2.1
|
|
|
|
|
|
2.2
|
|
|
|
|
|
3.1
|
|
|
|
|
|
3.2
|
|
|
|
|
|
3.3
|
|
|
|
|
|
4.1
|
|
|
|
|
|
4.2
|
|
|
|
|
|
4.3
|
|
|
|
|
|
4.4
|
|
|
|
|
|
4.5
|
|
|
|
|
|
4.6
|
|
|
|
|
|
4.7
|
|
|
|
|
|
Exhibit No.
|
|
Exhibit Index
|
|
|
|
4.8
|
|
|
|
|
|
4.9
|
|
|
|
|
|
4.10
|
|
|
|
|
|
4.11
|
|
|
|
|
|
4.12
|
|
|
|
|
|
4.13
|
|
|
|
|
|
4.14
|
|
|
|
|
|
4.15
|
|
|
|
|
|
4.16
|
|
|
|
|
|
4.17
|
|
|
|
|
|
4.18
|
|
|
|
|
|
4.19†
|
|
|
|
|
|
|
|
Westlake and its subsidiaries are party to other long-term debt instruments not filed herewith under which the total amount of securities authorized does not exceed 10% of the total assets of Westlake and its subsidiaries on a consolidated basis. Pursuant to paragraph 4(iii)(A) of Item 601(b) of Regulation S-K, Westlake agrees to furnish a copy of such instruments to the SEC upon request.
|
|
|
|
Exhibit No.
|
|
Exhibit Index
|
|
|
|
10.1
|
|
|
|
|
|
10.2
|
|
|
|
|
|
10.3
|
|
|
|
|
|
10.4†
|
|
|
|
|
|
10.5
|
|
|
|
|
|
10.6
|
|
|
|
|
|
10.7
|
|
|
|
|
|
10.8
|
|
|
|
|
|
10.9
|
|
|
|
|
|
10.1
|
|
|
|
|
|
10.11
|
|
|
|
|
|
10.12†
|
|
|
|
|
|
10.13
|
|
|
|
|
|
10.14+
|
|
|
|
|
|
10.15+
|
|
|
|
|
|
Exhibit No.
|
|
Exhibit Index
|
|
|
|
10.16+
|
|
|
|
|
|
10.17+
|
|
|
|
|
|
10.18+
|
|
|
|
|
|
10.19+
|
|
|
|
|
|
10.20
|
|
|
|
|
|
10.21†
|
|
|
|
|
|
10.22†
|
|
|
|
|
|
10.23†
|
|
|
|
|
|
10.24†
|
|
|
|
|
|
12.1†
|
|
|
|
|
|
21†
|
|
|
|
|
|
23.1†
|
|
|
|
|
|
31.1†
|
|
|
|
|
|
31.2†
|
|
|
|
|
|
32.1†
|
|
|
|
|
|
101.INS†
|
|
XBRL Instance Document.
|
|
|
|
101.SCH†
|
|
XBRL Taxonomy Extension Schema Document.
|
|
|
|
101.CAL†
|
|
XBRL Taxonomy Extension Calculation Linkbase Document.
|
|
|
|
101.DEF†
|
|
XBRL Taxonomy Extension Definition Linkbase Document.
|
|
|
|
101.LAB†
|
|
XBRL Taxonomy Extension Label Linkbase Document.
|
|
|
|
101.PRE†
|
|
XBRL Taxonomy Extension Presentation Linkbase Document.
|
†
|
Filed herewith.
|
+
|
Management contract, compensatory plan or arrangement.
|
|
|
|
WESTLAKE CHEMICAL CORPORATION
|
|
|
|
|
Date:
|
February 21, 2018
|
|
/
S
/ A
LBERT
C
HAO
|
|
|
|
Albert Chao, President and Chief Executive Officer
|
Signature
|
|
Title
|
|
Date
|
|
|
|
||
/S/
A
LBERT
C
HAO
|
|
President and Chief Executive Officer
(Principal Executive Officer)
|
|
February 21, 2018
|
Albert Chao
|
|
|||
|
|
|
||
/S/
M
.
S
TEVEN
B
ENDER
|
|
Executive Vice President and Chief Financial
Officer (Principal Financial Officer)
|
|
February 21, 2018
|
M. Steven Bender
|
|
|||
|
|
|
||
/S/
G
EORGE
J
.
M
ANGIERI
|
|
Senior Vice President and Chief Accounting
Officer (Principal Accounting Officer)
|
|
February 21, 2018
|
George J. Mangieri
|
|
|||
|
|
|
||
/S/
J
AMES
C
HAO
|
|
Chairman of the Board of Directors
|
|
February 21, 2018
|
James Chao
|
|
|||
|
|
|
||
/S/
A
LBERT
C
HAO
|
|
Director
|
|
February 21, 2018
|
Albert Chao
|
|
|||
|
|
|
||
/S/
R
OBERT
T
.
B
LAKELY
|
|
Director
|
|
February 21, 2018
|
Robert T. Blakely
|
|
|||
|
|
|
||
/S/
D
AVID
C
HAO
|
|
Director
|
|
February 21, 2018
|
David Chao
|
|
|
||
|
|
|
|
|
/S/
M
ICHAEL
J
.
G
RAFF
|
|
Director
|
|
February 21, 2018
|
Michael J. Graff
|
|
|||
|
|
|
||
/S/
M
ARIUS
H
AAS
|
|
Director
|
|
February 21, 2018
|
Marius Haas
|
|
|
||
|
|
|
|
|
/S/
D
OROTHY
C
.
J
ENKINS
|
|
Director
|
|
February 21, 2018
|
Dorothy C. Jenkins
|
|
|||
|
|
|
||
/S/
M
AX
L.
L
UKENS
|
|
Director
|
|
February 21, 2018
|
Max L. Lukens
|
|
|||
|
|
|
||
/S/
R
.
B
RUCE
N
ORTHCUTT
|
|
Director
|
|
February 21, 2018
|
R. Bruce Northcutt
|
|
|||
|
|
|
|
|
/S/
H
.
J
OHN
R
ILEY, JR.
|
|
Director
|
|
February 21, 2018
|
H. John Riley, Jr.
|
|
|||
|
|
|
|
|
/S/
J
EFFREY
S
HEETS
|
|
Director
|
|
February 21, 2018
|
Jeffrey Sheets
|
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
---|
DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
---|
No information found
Customers
No Suppliers Found
Price
Yield
Owner | Position | Direct Shares | Indirect Shares |
---|